ursodeoxycholic acid has been researched along with Bile Duct Obstruction in 377 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (2.39) | 18.7374 |
| 1990's | 116 (30.77) | 18.2507 |
| 2000's | 94 (24.93) | 29.6817 |
| 2010's | 105 (27.85) | 24.3611 |
| 2020's | 53 (14.06) | 2.80 |
| Authors | Studies |
|---|---|
| Green, RM; Hoda, F; Ward, KL | 1 |
| Camaioni, E; Clerici, C; Costantino, G; Fiorucci, S; Maloney, PR; Morelli, A; Parks, DJ; Pellicciari, R; Willson, TM | 1 |
| Assis, DN; Barbier, O; Boyer, JL; Gallucci, GM; Ghonem, NS; Hemme, C; Trottier, J | 1 |
| Cen, Y; Li, M; Wang, Z; Zeng, L | 1 |
| Colomé Rivero, G; García Romero, R; Martín de Carpi, J; Martorell Sampol, L; Mínguez Rodríguez, B; Molera Busoms, C | 1 |
| Chang, LW; Chen, LL; Liu, SY; Liu, W; Wang, J; Xie, M | 1 |
| Mankongpaisarnrung, C; McCashland, TM; Olivera-Martinez, MA; Rajendiran, G | 1 |
| Areia, AL; Melo, D; Moura, P | 1 |
| Bruneau, A; Guillot, A; Tacke, F | 1 |
| Mayo, MJ | 1 |
| Agirre-Lizaso, A; Aspichueta, P; Banales, JM; Bujanda, L; Echebarria, A; Esparza-Baquer, A; González-Romero, F; Hijona, E; Huici-Izagirre, M; Labiano, I; Luedde, T; Mann, DA; Marin, JJG; Marzioni, M; Milkiewicz, M; Milkiewicz, P; Monte, MJ; Olaizola, I; Olaizola, P; Perugorria, MJ; Rodrigues, PM; Sharif, O; Vucur, M | 1 |
| Ge, T; Li, D; Wang, Y; Xiao, Y; Yu, L; Zhang, T | 1 |
| Delija, B; Filipec Kanizaj, T; Lalovac, M; Martincevic, D; Mijic, M; Radetic, E; Saric, I; Sobocan, N | 1 |
| Harpavat, S; Hernandez, J; Hicks, MJ; Killelea, P; Sakhuja, S | 1 |
| Bloks, VW; de Boer, JF; de Vries, HD; Hovingh, MV; Koehorst, M; Kuipers, F; Li, R; Mulder, NL; Palmiotti, A; van Zutphen, T | 1 |
| Chai, J; Fu, L; Peng, S; Tao, L; Wang, H; Zhang, J; Zhang, X; Zhao, N; Zhou, Z | 1 |
| Lei, L; Li, Z; Ling, L; Liu, Y; Shao, Y; Xiong, Z | 1 |
| John, BV; Mansour, N; Shaker, M | 1 |
| Manns, MP; Nevens, F; Trauner, M | 1 |
| Beuers, U; Trampert, DC | 1 |
| Ichikawa, H; Iwasa, Y; Iwashita, T; Iwata, K; Iwata, S; Maruta, A; Mita, N; Mukai, T; Ohashi, Y; Okuno, M; Shimizu, M; Tezuka, R; Tomita, E; Uemura, S; Yoshida, K | 1 |
| Fejfar, T; Hůlek, P; Kaslová, B; Pařízek, A; Petr, T; Šimják, P; Vítek, L | 1 |
| Hirai, K; Honda, K; Murahashi, M; Takaki, Y | 1 |
| Chen, Y; Duan, Y; Han, J; Liu, L; Yang, S; Yang, X; Zhang, S | 1 |
| Baiocchi, L; Grassi, G; Lenci, I; Milana, M; Signorello, A | 1 |
| Chen, J; Huang, L; Jiang, X; Lan, K; Li, S; Zeng, L; Zhang, L; Zhu, Y | 1 |
| Bowlus, CL; Kowdley, KV; Levy, C; Mayo, MJ; Pratt, DS; Vuppalanchi, R; Younossi, ZM | 1 |
| Hirschfield, G; Levy, C; Manns, M | 1 |
| Kim, KA | 1 |
| Barba Bernal, R; Bonder, A; Castro, CM; Ferrigno, B; Goyes, D; Medina Morales, E; Patwardhan, VR; Trivedi, H | 1 |
| Bogdanos, DP; Rigopoulou, EI | 1 |
| John, BV; Levy, C; Trivella, J | 1 |
| Gao, L; He, X; Leung, PSC; Rojas, M; Yang, Y | 1 |
| Chen, W; Li, J; Li, W; Liu, W; Niu, X; Song, Y; Tu, P; Zhao, C | 1 |
| Cattaneo, M; Hurtado, C; Poniachik, J; Ramírez, F; Roblero, JP; Urzúa, Á | 1 |
| Fickert, P; Wagner, M | 1 |
| Feng, W; Hao, Z; Liu, Y; Ren, L; Song, Q; Zhang, L | 1 |
| Combalia, A; Dubreuil, M; Guañabens, N; Jurado, S; Monegal, A; Parés, A; Peris, P; Ruiz-Gaspà, S | 1 |
| Fujioka, M; Genda, T; Hara, M; Iwakami, N; Iwakami, SI; Kurokawa, K; Miyashita, Y; Sasaki, S; Takahashi, K | 1 |
| Bailey, S; Boolchandani, H; Caprio, M; Desai, P; Kazmi, SH; Mally, P | 1 |
| Fernando, G; Preston, N | 1 |
| Fickert, P; Jungwirth, E; Kolb-Lenz, D; Krones, E; Lee, JM; Marschall, HU; Moore, DD; Panzitt, K; Pollheimer, M; Thallinger, GG; Thorell, A; Trauner, M; Wagner, M; Xiao, R | 1 |
| Huang, WC; Lin, CK | 1 |
| Muriithi, FG | 1 |
| Abd El Baky, HEH; Badr, AM; Basanti, CWS; Draz, IH; El Sorogy, STM; Kotb, MA; Mosallam, D | 1 |
| Bernard, O; Jacquemin, E; Lykavieris, P | 1 |
| Corpechot, C; Montano-Loza, AJ | 1 |
| Chappell, LC; Hague, WM; Middleton, P; Thornton, JG; Walker, KF | 1 |
| Alvaro, D; Carpino, G; Craxi, A; Floreani, A; Invernizzi, P; Moschetta, A | 1 |
| García-Alix Pérez, A; Izurieta Pacheco, AC; Molera Busoms, C; Monfort Carretero, L; Prat Torres, C | 1 |
| Fejfar, T; Hůlek, P; Vaňásek, T | 1 |
| Tanaka, A | 1 |
| Caldez, MJ; Hunziker, W; Kaldis, P; Kausalya, PJ; Mohamed Ali, S; Ong, AGM; Van Hul, N; Woo, WL; Xu, J; Xu, S | 1 |
| Arab, JP; Candia, R; Kulkarni, AV; Kumar, P; Padaki, NR; Premkumar, M; Reddy, DN; Sharma, M; Tevethia, HV | 1 |
| Bittencourt, PL; Braga, MH; Cançado, ELR; Cançado, GGL; Codes, L; Coral, GP; Couto, CA; Cunha-Silva, M; da Cunha, SMCF; de Almeida E Borges, VF; de Faria Gomes, NM; de Lima Pace, FH; Faria, LC; Ferraz, MLG; Ivantes, CAP; Levy, C; Mendes, LSC; Nardelli, MJ; Oliveira, EMG; Oliveira, MB; Pessoa, MG; Rotman, V; Signorelli, IV; Terrabuio, DRB; Villela-Nogueira, CA | 1 |
| Barbier, O; Cieślak, A; Gobeil, S; Perreault, M; Thérien, A; Trottier, J; Verreault, M; Vohl, MC | 1 |
| Altorjay, I; Bergquist, A; Chapman, R; Denk, G; Färkkilä, M; Fickert, P; Greinwald, R; Halilbasic, E; Hirschfield, GM; Manns, MP; Marschall, HU; Nevens, F; Pröls, M; Reiter, FP; Schramm, C; Schrumpf, E; Spengler, U; Tornai, I; Trauner, M; Trivedi, P | 1 |
| Alvaro, D; Canonico, PL; Carbone, M; Craxi, A; Floreani, A; Gardini, I; Gasbarrini, A; Invernizzi, P; Kruger, P; Lanati, E; Marzioni, M; Mennini, FS; Muratori, L; Ronco, V; Vespasiani Gentilucci, U | 1 |
| Debray, D; Gonzales, E; Thébaut, A | 1 |
| Dickson, I | 1 |
| Chazouillères, O | 1 |
| Choe, YH; Kim, J; Paik, N; Paik, YH; Yang, B | 1 |
| Beuers, U; Hohenester, S | 1 |
| Fickert, P; Krones, E; Pollheimer, MJ; Rosenkranz, AR | 1 |
| Adeyemi, O; Alvarez-Laviada, A; Glukhov, AV; Gorelik, J; Ibrahim, E; Schultz, F; Trauner, M; Williamson, C | 1 |
| Dalekos, GN; Gatselis, NK; Lygoura, V; Polychronopoulou, E | 1 |
| Minuk, GY; Pollock, G; Uhanova, J | 1 |
| Alaca, N; Çağlayan Yeğen, B; Kurtel, H; Öktem, G; Özbeyli, D; Şahin, HH; Uslu, S; Yiğittürk, G | 1 |
| Boatto, G; Burrai, L; Chegaev, K; Di Guida, F; Lama, A; Lazzarato, L; Magliocca, S; Meli, R; Mollica, MP; Nieddu, M; Pirozzi, C; Raso, GM; Rimoli, MG; Russo, R; Santoro, A; Sodano, F | 1 |
| Cai, X; Chen, ZL; Jin, F; Li, G; Li, HR; Luo, L; Ma, Q; Wang, Y; Xue, J; Yang, F; Zhao, L; Zhou, X | 1 |
| Jansen, PLM | 1 |
| Coffey, A; Leung, DH; Quintanilla, NM | 1 |
| Aziz, K; Breton, E; Chailloux, P; Cousin, E; Cousin, I | 1 |
| Baumann, U; Beerbaum, P; Hohmann, D; Junge, C; Junge, N; Leiskau, C; Pfister, ED; Schröder, J | 1 |
| Chi, HY; Choi, MK; Choi, YA; Kang, YJ; Kim, MJ; Kwon, M; Shim, CK; Song, IS; Yoo, HH | 1 |
| Goldstein, J; Levy, C | 1 |
| Chambers, S; Jansen, E; Nikolova, V; Papacleovoulou, G; Pataia, V; Poston, L; Samuelsson, AM; Taylor, PD; Williamson, C | 1 |
| Düll, MM; Kremer, AE | 1 |
| Floreani, A; Grattagliano, I; Portincasa, P; Ubaldi, E | 1 |
| Ares, GJ; Buonpane, CL; Cohran, VC; Englert, EG; Helenowski, I; Hunter, CJ | 1 |
| Amelung, L; Arends, JE; de Bruijne, J; Leoni, MC; Lieveld, FI; van den Brink, J; van Erpecum, CP; van Erpecum, KJ | 1 |
| Aguilera, L; Albillos, A; Martínez, J | 1 |
| Abu Backer, F; Abu Mouch, S; Mari, A | 1 |
| Han, Y; Jia, G; Yuan, Z | 1 |
| Khan, MN; Middleton, JP; Niccum, M; Syed, S; Vergales, BD | 1 |
| Carey, EJ; Yokoda, RT | 1 |
| Andermatten, RB; Barosso, IR; Basiglio, CL; Ciriaci, N; Maidagan, PM; Martín, PL; Razori, MV; Roma, MG; Ruiz, ML; Sánchez Pozzi, EJ | 1 |
| Arab, JP; Arrese, M; Cabrera, D | 1 |
| Amano, N; Genda, T; Harada, K; Iijima, K; Matsumoto, K; Murata, A; Sato, S; Shimada, Y; Tomishima, K; Tsuzura, H | 1 |
| Baghdasaryan, A; Halilbasic, E; Trauner, M | 1 |
| Alvarez, L; Combalia, A; Dubreuil, M; Guañabens, N; Monegal, A; Parés, A; Peris, P; Ruiz-Gaspà, S | 1 |
| Cheng, D; Dong, JH; Guo, YJ; Jin, F; Pang, R; Tao, JY; Ye, P; Zhang, SL; Zhao, L | 1 |
| Forrest, D; Hagey, LR; Hofmann, AF; Ling, V; Liu, L; Sheps, JA; Wang, R | 1 |
| Gurung, V; Hague, W; Middleton, P; Milan, SJ; Thornton, JG | 1 |
| Denk, H; Eggertsen, G; Eller, K; Fickert, P; Halilbasic, E; Jaeschke, H; Krones, E; Langner, C; Moustafa, T; Pollheimer, MJ; Rosenkranz, AR; Silbert, D; Stokman, G; Thueringer, A; Trauner, M; Wagner, CA; Wells, RG; Yang, M | 1 |
| Czaja, AJ | 1 |
| Chen, XQ; Deng, YN; Shan, QW; Tang, Q; Wang, LL; Yun, X | 1 |
| Bulut, G; Calka, O; Dulger, AC; Ozkol, HU | 1 |
| Buryova, H; Chalupsky, K; Gregor, M; Jirouskova, M; Kanchev, I; Sedlacek, R; Zbodakova, O | 1 |
| Bolia, R; Goel, D; Poddar, U; Srivastava, A; Yachha, SK | 1 |
| Boyer, JL; Cai, SY; Mennone, A; Soroka, CJ | 1 |
| Abidi, S; Baillie, R; Blood, AB; Dueker, S; Gordi, T; Hopper, AO; Pegis, P; Power, GG; Vasquez, H; Vuong, le T | 1 |
| Burdina, EG; Gurova, NIu; Manushkin, ON; Novozhenova, EV; Vasil'chenko, SA | 1 |
| Chamulitrat, W; Pathil, A; Sellinger, M; Stremmel, W; Xu, W | 1 |
| Anantharajah, A; Grigg, A; Lokan, J; Yeh, P | 1 |
| Mahmoud, YI; Saad, RA | 1 |
| Bell, C; Graves, A; Imseis, EM; Mangalat, N | 1 |
| Adams, DH; Beuers, U; Dyson, JK; Hirschfield, GM; Jones, DE; Lindor, KD; Mann, DA | 1 |
| Assis, DN; Boyer, JL; Ghonem, NS | 1 |
| Basu, S; Bhattacharya, A | 1 |
| Kang, YZ; Liu, YH; Shen, ZY; Sun, XY | 1 |
| Anastaze Stelle, K; Cachat, F; Chehade, H; Perez, MH | 1 |
| Gavrilova, NP; Radchenko, VG; Seliverstov, PV; Tatarova, NA | 1 |
| Ali, SW; Hassan, MU; Khan, SH; Malik, D; Pakala, R; Pasupula, M; Rather, TA; Yadav, N | 1 |
| Duduk, NI; Kravchuk, RI; Zimatkin, SM | 1 |
| Mahmoud, YI | 1 |
| Sadeghi, R | 1 |
| Malik, D | 1 |
| Agrawal, DK; Kovilam, O; Larson, SP | 1 |
| Cecchi, N; Garzi, A; Mandato, C; Orso, G; Vajro, P; Veropalumbo, C | 1 |
| Halilbasic, E; Kuntner, C; Langer, O; Mairinger, S; Müller, M; Römermann, K; Stieger, B; Trauner, M; Visentin, M; Wanek, T | 1 |
| Ali, AH; Lindor, KD | 1 |
| Fleischer, AB; Pongcharoen, P | 1 |
| Mittal, A | 1 |
| Alawad, AS; Levy, C | 1 |
| Hassan, HM; Jiang, Z; Li, X; Liu, R; Sun, R; Yang, H; Yuan, Z; Zhang, L | 1 |
| Biswal, N; Chandrasekaran, V; Jagadisan, B; Nair, VS | 1 |
| Eller, K; Fickert, P; Frauscher, B; Grahammer, F; Huber, TB; Kirsch, AH; Krones, E; Marschall, HU; Pollheimer, MJ; Racedo, S; Rosenkranz, AR; Ståhlman, M; Trauner, M; Wagner, K; Wahlström, A | 1 |
| Halilbasic, E; Steinacher, D; Trauner, M | 1 |
| Azzaroli, F; Colecchia, A; Di Biase, AR; Festi, D; Lodato, F; Mazzella, G; Montagnani, M; Roda, A; Roda, E; Simoni, P | 1 |
| Castaño, B; Gonzalez-Buitrago, JM; Jimenez, S; Marin, JJ; Perez, MJ; Serrano, MA | 1 |
| Moreno Villares, JM | 1 |
| Jorgensen, BR; Mackenzie, PI; Meech, R; Miners, JO; Rogers, A; Treloar, J | 1 |
| Kotb, MA | 1 |
| Bhatia, K; Grossmith, AK; Heazell, AE | 1 |
| Ko, KS; Li, J; Li, TW; Lu, SC; Oh, P; Ramani, K; Xia, M; Yang, H | 1 |
| Gotthardt, D; Klöters-Plachky, P; Kulaksiz, H; Rost, D; Rudolph, G; Stiehl, A | 1 |
| Cubells, E; Garzón, L; Ledo, A; Sáenz, P; Vento, M | 1 |
| Briley, A; Broughton Pipkin, F; Chambers, J; Chappell, L; Gurung, V; Thornton, J; Williamson, C | 1 |
| Adam, R; Reinshagen, K; Trunk, M; Wessel, LM | 1 |
| Bhattacharya, A; Das, A; Poddar, U; Rao, KL; Singh, K; Thapa, BR | 1 |
| Liu, XD; Wang, GJ; Yang, J; Yin, XF; Zhang, XY | 1 |
| Akoglu, B; Faust, D; Milovic, V; Ristic, G | 1 |
| Giliberti, P; Iorio, R; Nicastro, E; Raimondi, F; Tufano, M; Vegnente, A | 1 |
| Fábrega, E; Pons-Romero, F; Terán, A | 1 |
| Alex, G; Clarnette, T; Rosenbaum, J | 1 |
| Ko, K; Li, J; Li, TW; Lu, SC; Oh, P; Xia, M; Yang, H | 1 |
| Alvaro, D; Attili, AF; Bragazzi, MC; Callea, F; Giubilo, F; Merli, M | 1 |
| Aehlen, A; Ehmer, U; Erichsen, TJ; Kalthoff, S; Manns, MP; Strassburg, CP | 1 |
| Paumgartner, G | 1 |
| Gotthardt, D; Kloeters-Plachky, P; Kulaksiz, H; Rost, D; Rudolph, G; Stiehl, A | 1 |
| Gershwin, ME; Heathcote, EJ; Hirschfield, GM | 1 |
| Beuers, U; Denk, GU; Ferdinandusse, S; Fickert, P; Fuchsbichler, A; Hofmann, AF; Invernizzi, P; Kulik, W; Maitz, S; Rust, C; Trauner, M; Wimmer, R | 1 |
| Eisendle, K; Graziadei, I; Höpfl, R; Müller, H; Ortner, E; Talasz, H; Vogel, W | 1 |
| Cardella, F; Corsello, G; Liotta, A; Maggio, MC | 1 |
| Ackermann, O; Bernard, O; Branchereau, S; Franchi-Abella, S; Gonzales, E; Jacquemin, E; Mourier, O | 1 |
| Bozdag, S; Dilmen, U; Erdeve, O; Gokmen, T; Oguz, SS; Uras, N | 1 |
| Chaabane, NB; Njim, L; Safer, L; Saffar, H; Zakhama, A | 1 |
| Kherbèche, H | 1 |
| Drolz, A; Fuhrmann, V; Trauner, M | 1 |
| Basiglio, CL; Boaglio, AC; Crocenzi, FA; Roma, MG; Sánchez Pozzi, EJ; Toledo, FD | 1 |
| Celen, S; Danisman, N; Deveer, R; Engin-Ustun, Y; Eryilmaz, OG; Mollamahmutoğlu, L; Oksuzoglu, A; Tonguç, E | 1 |
| Dick, AA; Healey, P; Horslen, SP; Hsu, E; Javid, PJ; Malone, FR; Sunseri, M | 1 |
| Casadio, C; Gaddoni, G; Giacomoni, P; Lanzanova, G; Maio, V; Patrizi, A; Savoia, F; Spadola, G; Tabanelli, M; Zago, S | 1 |
| Chambers, J; Tuson, A | 1 |
| Bastiaansen, BA; Beuers, U; Dilger, K; Hohenester, S; Rust, C; Schaap, FG; Winkler-Budenhofer, U | 1 |
| McKiernan, P | 1 |
| Beuers, U; Maillette de Buy Wenniger, LJ; Oude Elferink, RP | 1 |
| Canbay, A; Fingas, CD; Herzer, K | 1 |
| Carey, EJ; Lindor, KD | 1 |
| Jacquemin, E | 1 |
| Erlinger, S | 1 |
| Choi, MK; Han, JM; Hwang, SY; Kim, HG; Lee, JS; Park, HJ; Son, CG; Son, SW; Wang, JH | 1 |
| Denk, H; Durchschein, F; Fickert, P; Halilbasic, E; Krones, E; Moustafa, T; Pollheimer, MJ; Silbert, D; Thüringer, A; Trauner, M; Zollner, G | 1 |
| Duggan, C; Raphael, BP | 1 |
| Allgaier, HP; Bassler, D; Galandi, D; Schwarzer, G | 1 |
| Emmanuel, J; Micheline, D; Serge, E | 1 |
| Beuers, U; Paumgartner, G | 2 |
| Wang, L; Xie, W; Yao, D | 1 |
| Matsuzaki, Y | 1 |
| Palmeira, CM; Rolo, AP; Wallace, KB | 1 |
| Berkenbosch, JW; George, R; Stevens, A; Tobias, J; Turpin, J | 1 |
| Bravo, A; Briz, O; Macias, RI; Marin, JJ; Meier, PJ; Pascual, MJ; Serrano, MA; St-Pierre, MV; Stieger, B; Vallejo, M | 1 |
| Black, RE; Book, LS; Jackson, WD; Johnson, DG; Matlak, ME; Meyers, RL; O'Gorman, MA | 1 |
| Benedetti, A; Macarri, G; Marucci, L | 1 |
| Catania, VA; Crocenzi, FA; Luquita, MG; Mottino, AD; Pellegrino, JM; Rodríguez Garay, EA; Roma, MG; Sánchez Pozzi, EJ | 1 |
| Karvonen, AL | 1 |
| Herrmann, T; Meier, PJ; Rost, D; Sauer, P; Schmidts, HL; Stieger, B; Stiehl, A; Stremmel, W | 1 |
| Geubel, AP; Rahier, J; Sempoux, C | 1 |
| Hofmann, AF | 3 |
| Il'chenko, AA; Vikhrova, TV | 1 |
| Chambers, J; Eggington, E; Elias, E; Gallagher, R; Milkiewicz, P; Weaver, J | 1 |
| Szalay, F | 1 |
| Ertekin, V; Orbak, Z; Selimoğlu, MA | 1 |
| Forget, PP; Heemskerk, J; Heineman, E; Sie, GH; Van den Neucker, AM; van Heurn, LW | 1 |
| Binz, J; Dennis, S; Desai, B; Goodwin, B; Jones, SA; Kliewer, SA; Liu, Y; Luo, G; MacKenzie, KI; Mansfield, TA; Numerick, MJ | 1 |
| Ribal'chenko, VK; Sinel'nik, OD; Sinel'nik, TB | 1 |
| Borras, C; Carretero, J; Cutrin, J; Pallardó, FV; Pereda, J; Poli, G; Sastre, J; Serviddio, G; Vendemiale, G; Viña, J | 1 |
| Agca, E; Akcay, A; Simsek, H | 1 |
| Chang, MH; Chen, CY; Chen, HL; Chou, HC; Hsieh, WS; Tsao, PN | 1 |
| Hernandez, B; Jimenez, S; Macias, RI; Marin, JJ; Monte, MJ; Serrano, MA | 1 |
| Blum, HE; Kreisel, W; Opitz, OG; Thimme, R | 1 |
| El-Rifai, N; Gottrand, F | 1 |
| Chapman, RW; Mitchell, SA | 2 |
| Fickert, P; Trauner, M; Wagner, M; Zollner, G | 1 |
| Chapman, RW; Cullen, SN | 1 |
| Catania, VA; Crocenzi, FA; D'Andrea, V; Luquita, MG; Mottino, AD; Ochoa, JE; Pellegrino, JM; Sánchez Pozzi, EJ | 1 |
| Duran, C; Gonzalez-Buitrago, JM; Macias, RI; Marin, JJ; Monte, MJ; Perez, MJ | 1 |
| Copaci, I; Iliescu, L; Micu, L; Voiculescu, M | 1 |
| Macias, RI; Marin, JJ; Perez, MJ | 1 |
| Abulaimoun, B; Al-Hathlol, K; Al-Madani, A; Al-Saif, S; Al-Tawil, K; El-Demerdash, A | 1 |
| Alpini, G; Benedetti, A; Fava, G; Francis, H; Glaser, S; Mancino, MG; Marzioni, M; Reichenbach, R; Summers, R; Ueno, Y; Venter, J | 1 |
| Cheng, F; Diac, M; Girling, J; Goodman, J; Kenyon, A; Nelson-Piercy, C; Shennan, A; Tribe, RM; Williamson, C | 1 |
| Asciutti, S; Baldoni, M; Camaioni, E; Castellani, D; Clementi, M; Clerici, C; Fiorucci, S; Giuliano, V; Mazzocchi, A; Morelli, A; Morelli, O; Nardi, E; O'Connell, NC; Orlandi, S; Pellicciari, R; Renga, B; Sabatino, G; Sadeghpour, B; Setchell, KD | 1 |
| Beuers, U | 2 |
| Jimenez, S; Macias, RI; Marin, JJ; Monte, MJ; Serrano, MA | 1 |
| Beuers, U; Pusl, T | 1 |
| Bruzzese, E; Colombo, C; De Marco, G; Di Caro, S; Guarino, A; Mambretti, D; Simoni, P; Sordino, D; Tramontano, A | 1 |
| Fickert, P; Geier, A; Trauner, M | 1 |
| O'Leary, JG; Pratt, DS | 1 |
| Georgadakis, G; Gerovasilis, F; Karamouti, M | 1 |
| Barbu, V; Beaussier, M; Callard, P; Fouassier, L; Housset, C; Lasnier, E; Lienhart, A; Mergey, M; Rey, C; Schiffer, E; Scoazec, JY; Stieger, B; Wendum, D | 1 |
| Allard, JP; Raman, M | 1 |
| Fauler, G; Gurakuqi, G; März, W; Putz-Bankuti, C; Scharnagl, H; Stadlbauer, V; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M | 1 |
| Duarte-Rojo, A; Martínez-Benítez, B; Sánchez-Osorio, M; Torre, A; Uribe, M | 1 |
| Btaiche, IF; San Luis, VA | 1 |
| Gabe, SM; Lloyd, DA | 1 |
| Dunn, JM; McNair, A | 1 |
| Arslanoglu, S; Boehm, G; Moro, GE; Tauschel, HD | 1 |
| Shan, RB; Zhu, MZ | 1 |
| Itokazu, K; Sano, N; Yamanaka, M; Yokote, M | 1 |
| Kanai, S; Kitani, K | 1 |
| Han-Markey, T; Schumacher, RE; Teitelbaum, DH | 1 |
| Accatino, L; Arrese, M; Koenig, C; Pizarro, M; Solís, N | 1 |
| da Silva, RC; Davies, MH; Elias, E; Jones, SR; Weaver, JB | 1 |
| Poupon, R; Poupon, RE | 2 |
| Bendayan, M; Lambert, M; Levy, E; Paradis, K; Thibault, L | 1 |
| Bonnefis, MT; Calmus, Y; Chereau, C; Podevin, P; Poupon, R; Veyrunes, C | 1 |
| Piotrowicz, A; Polkey, M; Wilkinson, M | 1 |
| Cruz, C; Estanes, A; Pedraza-Chaverrí, J; Poo, JL; Uribe, M | 1 |
| Cagnoni, C; Carrara, GC; Castelli, A; Concesi, C; Crippa, G; Girometta, S; Pancotti, D; Pierfranceschi, MG; Sverzellati, E; Tacchini, G | 1 |
| Finnie, I; Gilmore, I; Lombard, MJ; Rhodes, JM; Sutton, R | 1 |
| Stiehl, A | 3 |
| Akiyama, K; Aoshima, M; Hasegawa, T; Hotta, S; Kashiwaya, T; Katou, T; Kimura, A; Makino, I; Nakamura, K | 1 |
| Besson, I; de Lédinghen, V; Fabre, M; Levillain, P; Morichau-Beauchant, M; Palazzo, L; Silvain, C | 1 |
| Barrioz, T; Beauchant, M; Besson, I; de Ledinghen, V; Ingrand, P; Silvain, C | 1 |
| Wilcox, MH | 1 |
| Beau, P; Beauchant, M; Ingrand, P; Labat-Labourdette, J | 1 |
| van Berge-Henegouwen, GP; Van de Meeberg, PC; van Erpecum, KJ | 1 |
| Bianchi, L; Reichen, J | 1 |
| Luketic, VA; Sanyal, AJ | 1 |
| al-Quaiz, MN; O'Grady, JG; Tredger, JM; Williams, R | 1 |
| van Berge Henegouwen, GP; van de Meeberg, PC; van Erpecum, KJ | 1 |
| Dumont, M; Erlinger, S; Jacquemin, E; Mallet, A | 1 |
| Bailey, RJ; Blendis, LM; Cauch-Dudek, K; Ghent, CN; Heathcote, EJ; Michieletti, P; Minuk, GY; Pappas, SC; Scully, LJ; Walker, V | 1 |
| Bertault-Perès, P; Durand, A; Mesdjian, E; Montet, JC; Queneau, PE | 1 |
| Reichen, J | 1 |
| Kanai, S; Kitani, K; Ohta, M; Tsukahara, K | 1 |
| Araki, T; Ishizaki, K; Kinbara, S; Miyazawa, N; Takeuchi, Y | 1 |
| Accatino, L; Arrese, M | 1 |
| Khandelwal, M; Malet, PF | 1 |
| Faccioli, AM; Frezza, EE; Galligioni, A; Gerunda, GE; Giacomini, A; Neri, D; Plebani, M; Tiribelli, C | 1 |
| Minagawa, K; Sano, N; Takikawa, H; Yamanaka, M | 1 |
| Idei, T | 1 |
| Sano, N; Takikawa, H; Yamanaka, M | 1 |
| Bruining, HA; den Toom, R; Nijs, HG; Plaisier, PW; Terpstra, OT; van der Hul, RL | 1 |
| Duraj, F; Ericzon, B; Rafael, E; Rudström, H; Wilczek, H | 1 |
| Forsberg, L; Hägerstrand, I; Lyttkens, K; Prytz, H | 1 |
| Lacaille, F | 1 |
| Rudolph, G; Sauer, P; Stiehl, A; Theilmann, L | 1 |
| Baumgartner, U; Farthmann, EH; Reinhardt, M; Ruf, G; Schölmerich, J; Sellinger, M | 1 |
| Manns, MP; Schmidt, HH | 1 |
| Parés, A; Rodés, J | 1 |
| O'Brien, CB; Reddy, KR; Saul, SH; Shields, DS | 1 |
| Barabino, A; Clayton, PT; Johnson, AW; Marazzi, MG; Mills, KA | 1 |
| Bernard, B; Bouvier, E; Cabrol, A; Cadranel, JF; Dorent, R; Gandjbakhch, I; Gerhardt, M; Ghoussoub, JJ; Lunel, F; Myara, A; Opolon, P; Trivin, F | 1 |
| Guarino, A; Iorio, R; Spagnuolo, MI; Vegnente, A | 1 |
| Gerber, MA; Jacob, S; Mason, AL; Perrillo, RP | 1 |
| Chan, G; Clandinin, MT; Duerksen, DR; Gramlich, L; Meddings, JB; Thomson, AB; Van Aerde, JE | 1 |
| Di Leo, A; Diaferia, A; Iacovizzi, C; Loizzi, P; Nicastri, PL; Tartagni, M | 1 |
| Bianchi, L; Dienes, HP; Gerken, G; Helmreich-Becker, I; Lohse, AW; Meyer zum Büschenfelde, KH; Protzer, U | 1 |
| Capron, JP; Erlinger, S; Lévy, S | 1 |
| Alvaro, D | 1 |
| Boyer, J; Clerici, C; Gartung, C; Morelli, A; Rodrigues, CM; Setchell, KD; Solinas, A | 1 |
| Camargo, CA; Clavien, PA; Fitz, JG; Harland, RC; Sharara, AI | 1 |
| Chazouillères, O; Haniche, M; Jian, R; Marteau, P; Poupon, R | 1 |
| Hori, Y; Ohyanagi, H | 1 |
| Aoki, K; Kimura, A; Mahara, R; Suzuki, M; Tohma, M; Yamakawa, R | 1 |
| Benz, C; Rudolph, G; Sauer, P; Stiehl, A; Stremmel, W; Theilmann, L; Walker, S | 1 |
| Arslan, S; Güllú, IH; Kadayifci, A; Savas, MC | 1 |
| Cağlar, M; Göğüş, S; Gürakan, F; Kale, G; Koçak, N; Yüce, A | 1 |
| Teitelbaum, DH | 1 |
| Bouscarel, B; Ceryak, S; Fromm, H; Gettys, TW; Le, M; Matsuzaki, Y; Shoda, J | 1 |
| Bishop, WP; McCray, PB; Scher, H | 1 |
| Araki, T; Hirabayashi, N; Ishizaki, K; Kasai, H; Kinbara, S; Sakakura, H | 1 |
| Chan, CY; Chang, FY; Hsu, SH; Lee, SD; Lin, SH; Lu, CL | 1 |
| Bährle, S; Dengler, TJ; Kübler, W; Stiehl, A; Szabó, G; Theilmann, L; Zimmermann, R | 1 |
| Bouscarel, B; Fromm, H; Gettys, TW; Le, M; Matsuzaki, Y | 1 |
| Aguilar, HI; Botla, R; Bronk, SF; Gores, GJ; Miyoshi, H | 1 |
| Jonas, MM; Perez-Atayde, A; Srivastava, M | 1 |
| Arenas, JI; Barrio, J; Castiella, A; Cosme, A; García-Bengoechea, M; Indart, A; Lobo, C; López, P | 1 |
| Beuers, U; Boyer, JL; Paumgartner, G | 1 |
| Javitt, NB | 1 |
| Leuschner, U | 2 |
| Bushma, MI; Karaedova, LM; Karpovich, VE; Khomich, TI; Konovalenko, OV; Lashak, LK; Legon'kova, LF; Zverinskiĭ, IV | 1 |
| Batta, AK; Salen, G | 1 |
| Benz, C; Klöters-Plachky, P; Rudolph, G; Sauer, P; Stiehl, A; Stremmel, W | 1 |
| McDonald, JA | 1 |
| Batts, KP; Gleich, GJ; Kephart, GM; Kita, H; Lindor, KD; Nakamura, A; Sato, S; Suzuki, K; Tarara, JE; Yamazaki, K | 1 |
| Clark, TJ; Dwarakanath, L; Weaver, JB | 1 |
| Kobayashi, S; Kumai, T; Nakaya, S; Nakura, H; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
| Amii, LA; Moss, RL | 1 |
| Benedetti, P; de Lalla, F; Fabris, P; Mazzella, G; Nicolin, R; Pellizzer, G; Tositti, G; Zanetti, AR | 1 |
| Descargues, G; Marpeau, L; Verspyck, E | 1 |
| Rodrigues, CM; Steer, CJ | 2 |
| Beauchant, M; De Lédinghen, V; Desaint, B; Greef, M; Grollier, G; Ingrand, P; Le Sidaner, A; Legoux, JL; Moesch, C; Person, B; Sautereau, D | 1 |
| Bushma, MI; Legon'kova, LF; Vasil'ev, AV; Zverinskiĭ, IV | 1 |
| Chazouillères, O; Poupon, R; Poupon, RE | 1 |
| Kowdley, KV | 1 |
| Anna, M; Antonio, C; Azzaroli, F; Bovicelli, L; Colecchia, A; Constance, M; Davide, F; Enrico, R; Festi, D; Francesco, A; Giovanni, N; Giuliana, S; Luciano, B; Mazzella, G; Miracolo, A; Mwangemi, C; Nicola, R; Nigro, G; Patrizia, S; Rizzo, N; Roda, E; Simonazzi, G; Simoni, P | 1 |
| Marschall, HU; Matern, S; Purucker, E; Winograd, R | 1 |
| Sanyal, A | 1 |
| Abdullah, MA; Abomelha, AM; Al-Hasnan, Z; Okamoto, E | 1 |
| Al-Ansari, N; Shneider, BL | 1 |
| Burrows, E; Burrows, RF; Clavisi, O | 1 |
| Bentley, RC; Dougherty, F; Hochman, JA; Treem, WR | 1 |
| Btaiche, IF; Khalidi, N | 1 |
| Attali, M; Borchardt, J; Mahlab, K; Malnick, SD; Sokolowski, N | 1 |
| Azzaroli, F; Ferrara, F; Festi, D; Giovanelli, S; Liva, S; Mazzella, G; Nigro, G; Roda, E | 1 |
| Gatzen, M; Pausch, J | 1 |
| Linares Rodríguez, A | 1 |
| Alpini, G; Angelico, M; Baiocchi, L; Francis, H; Glaser, S; Lesage, G; Marzioni, M; Phinizy, JL; Ueno, Y | 1 |
| Gong, J; Han, B; Xu, M; Xue, L | 1 |
| Dolfin, T; Raz, A; Regev, RH; Stolar, O | 1 |
| Guma, C; Viola, L | 1 |
| Chazalette, JP; Figarella, C; Galabert, C; Lecuire, A; Lengrand, D; Montet, JC; Sotta, C | 1 |
| Hayakawa, T; Hoshino, M; Katagiri, K; Nakai, T; Ohiwa, T | 1 |
| Fisher, LD; Fried, RH; McDonald, GB; Murakami, CS; Sullivan, KM; Willson, RA | 1 |
| Braillon, A; Dumont, M; Erlinger, S; Feldmann, G; Gaudin, C; Lebrec, D; Poo, JL | 1 |
| Duane, WC; Eckfeldt, JH; Furne, J; Hillstrom, J; Levitt, MD | 1 |
| Hayashi, H; Higuchi, T; Hishida, N; Isomura, T; Takeshima, H | 1 |
| Aldini, R; Bazzoli, F; Festi, D; Mazzella, G; Parini, P; Roda, E | 1 |
| Egestad, B; Marschall, HU; Matern, H; Matern, S; Sjövall, J; Wietholtz, H | 1 |
| Lehnert, W; Marschall, HU; Matern, H; Matern, S; Schill, A; Schumacher, B; Sjövall, J | 1 |
| Calmus, Y; Poupon, R | 1 |
| Mathisen, O; Omland, E | 1 |
| Burnes, J; Lindor, KD | 1 |
| de Caestecker, JS; Jazrawi, RP; Northfield, TC; Petroni, ML | 1 |
| Beuers, U; Fischer, S; Paumgartner, G; Spengler, U | 1 |
| Chazalette, JP; Dimier, JL; Galabert, C; Lengrand, D; Montet, JC | 1 |
| Montet, JC | 1 |
| Heuman, DM; Hylemon, PB; McCall, J; Mills, AS; Pandak, WM; Vlahcevic, ZR | 1 |
| Borum, M; Fromm, H; Malet, PF | 1 |
| Riely, CA | 1 |
| Gams, E; Kallinowski, B; Kommerell, B; Stiehl, A; Theilmann, L; Zimmermann, R | 1 |
| Kaplan, MM | 1 |
| Berenson, MM; Bjorkman, DJ; Gunther, C; Samowitz, WS | 1 |
| Bohdan, PM; Heuman, DM; Hylemon, PB; Sirica, AE; Vlahcevic, ZR | 1 |
| Cotting, J; Lentze, MJ; Reichen, J | 1 |
| Kurtz, W; Leuschner, U | 1 |
| Bailey, ME; Pain, JA | 1 |
| Hayakawa, T; Higashi, K; Hoshino, M; Ito, K; Katagiri, K; Miyaji, M; Takeuchi, T; Tsukada, K; Yamamoto, T | 1 |
| Blenkharn, JI; Blumgart, LH; Cohen, J; Matkin, J; McConnell, JS; Moore, RH; Thompson, JN | 1 |
| Barr, J; Blenkharn, JI; Blumgart, LH; Cohen, J; McConnell, JS; Thompson, JN | 1 |
| Luciani, A; Massari, M; Montanari, P; Nora, A; Zandomeneghi, R | 1 |
| Hayakawa, T; Higashi, K; Hoshino, M; Inaguma, H; Ito, M; Katagiri, K; Miyaji, M; Takeuchi, T; Tohyama, K; Tsunoka, S | 1 |
118 review(s) available for ursodeoxycholic acid and Bile Duct Obstruction
| Article | Year |
|---|---|
Macrophages in cholangiopathies.
Topics: Animals; Bile Acids and Salts; Cholangitis, Sclerosing; Cholestasis; Humans; Inflammation; Macrophages; Mice; Ursodeoxycholic Acid | 2022 |
Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Fibrosis; Humans; Inflammation; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients.
Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholestasis; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid | 2022 |
Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis.
Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Prognosis; Ursodeoxycholic Acid | 2022 |
Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases
Topics: Cholestasis; Humans; Liver Cirrhosis, Biliary; Membrane Transport Proteins; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2023 |
Secondary bile acids and the biliary epithelia: The good and the bad.
Topics: Bile Acids and Salts; Biliary Tract; Cholestasis; Humans; Liver; Ursodeoxycholic Acid | 2023 |
Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis.
Topics: Alanine Transaminase; Bile Acids and Salts; Bilirubin; Child; Cholestasis; Humans; Ursodeoxycholic Acid | 2023 |
New Treatment Paradigms in Primary Biliary Cholangitis.
Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Peroxisome Proliferator-Activated Receptors; Pruritus; Quality of Life; Ursodeoxycholic Acid | 2023 |
[Diagnosis and Treatment of Primary Biliary Cholangitis].
Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid | 2023 |
Role of autoantibodies in the clinical management of primary biliary cholangitis.
Topics: Antibodies, Antinuclear; Autoantibodies; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2023 |
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
Topics: Animals; Cholangitis; Cholestasis; Fibrosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2023 |
Drug Therapies for Chronic Cholestatic Liver Diseases.
Topics: Animals; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Disease Progression; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2020 |
Prolonged cholestasis following endoscopic retrograde cholangiopancreatography, a rare complication of contrast agent induced liver injury: A case report and literature review.
Topics: Aged; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Cholestyramine Resin; Contrast Media; Drug Therapy, Combination; Humans; Male; Ursodeoxycholic Acid | 2020 |
Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy.
Topics: Bilirubin; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2021 |
Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.
Topics: Charcoal; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Dexamethasone; Drugs, Chinese Herbal; Female; Fetal Distress; Galactans; Glucocorticoids; Humans; Mannans; Plant Gums; Pregnancy; Pregnancy Complications; Pruritus; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Stillbirth; Ursodeoxycholic Acid | 2020 |
Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel.
Topics: Bile Acids and Salts; Cholestasis; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2020 |
Current understanding of primary biliary cholangitis.
Topics: Carcinoma, Hepatocellular; Cholestasis; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Ursodeoxycholic Acid | 2021 |
Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis.
Topics: Chenodeoxycholic Acid; Cholestasis; Humans; Liver Cirrhosis, Biliary; Non-alcoholic Fatty Liver Disease; Pharmaceutical Preparations; Ursodeoxycholic Acid | 2021 |
[Physiopathology and management of cholestatic pruritus in children].
Topics: Anion Exchange Resins; Biliary Tract Surgical Procedures; Child; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 CYP3A Inducers; Humans; Liver Transplantation; Narcotic Antagonists; Pruritus; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Sorption Detoxification; Ursodeoxycholic Acid | 2017 |
[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
Topics: Adult; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Humans; Liver Diseases; Ursodeoxycholic Acid | 2017 |
Cholemic nephropathy - Historical notes and novel perspectives.
Topics: Acute Kidney Injury; Animals; Bile Acids and Salts; Bile Ducts; Bilirubin; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Epithelial Cells; Hepatocytes; Humans; Jaundice, Obstructive; Kidney Tubules; Liver; Renal Elimination; Ursodeoxycholic Acid | 2018 |
New therapies target the toxic consequences of cholestatic liver disease.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Chronic Disease; Humans; Organic Anion Transporters, Sodium-Dependent; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Symporters; Ursodeoxycholic Acid | 2018 |
Novel and emerging therapies for cholestatic liver diseases.
Topics: Bile Acids and Salts; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Drug Therapy, Combination; Elasticity Imaging Techniques; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2018 |
Management of Chronic Hepatic Itch.
Topics: Analgesics, Opioid; Anion Exchange Resins; Antipruritics; Bezafibrate; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 Enzyme Inducers; Drainage; Humans; Hypolipidemic Agents; Membrane Glycoproteins; Methylamines; Narcotic Antagonists; Prevalence; Pruritus; Rifampin; Thiazepines; Ursodeoxycholic Acid | 2018 |
Risk stratification and treatment of primary biliary cholangitis.
Topics: Adult; Age Factors; Alkaline Phosphatase; Biomarkers; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Fibric Acids; Glucocorticoids; Humans; Liver Cirrhosis; Liver Transplantation; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure; Ursodeoxycholic Acid | 2019 |
[PRIMARY BILIARY CHOLANGITIS: THERAPEUTIC APPROACH IN THE MODERN ERA].
Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Quality of Life; Ursodeoxycholic Acid | 2018 |
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Topics: Adult; Biliary Tract; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Immunologic Factors; Life Expectancy; Prevalence; Prognosis; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
Topics: Bile Acids and Salts; Cholestasis; Humans; Liver; Liver Diseases; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2019 |
Nuclear receptors as drug targets in cholestatic liver diseases.
Topics: Animals; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Constitutive Androstane Receptor; Homeostasis; Humans; Ligands; Peroxisome Proliferator-Activated Receptors; Pregnane X Receptor; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid; Receptors, Steroid; Signal Transduction; Ursodeoxycholic Acid | 2013 |
Interventions for treating cholestasis in pregnancy.
Topics: Charcoal; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Drugs, Chinese Herbal; Female; Galactans; Humans; Mannans; Plant Gums; Pregnancy; Pregnancy Complications; Pruritus; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Ursodeoxycholic Acid | 2013 |
Diagnosis and management of the overlap syndromes of autoimmune hepatitis.
Topics: Adult; Alkaline Phosphatase; Cholangitis, Sclerosing; Cholestasis; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2013 |
Novel therapeutic targets in primary biliary cirrhosis.
Topics: Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Ursodeoxycholic Acid | 2015 |
Fibrates and cholestasis.
Topics: Biomarkers; Cholestasis; Female; Fibric Acids; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; PPAR alpha; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Streptococcus pneumoniae-Associated Hemolytic and Uremic Syndrome With Cholestasis: A Case Report and Brief Literature Review.
Topics: Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Female; Humans; Peritoneal Dialysis; Pneumonia, Pneumococcal; Syndrome; Uremia; Ursodeoxycholic Acid | 2016 |
Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.
Topics: Animals; Cholestasis; Female; Humans; Immunity; Liver; Pregnancy; Pregnancy Complications; Th1-Th2 Balance; Th2 Cells; Ursodeoxycholic Acid | 2016 |
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Topics: Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Acids, Omega-3; Fish Oils; Humans; Infant; Infant, Newborn; Liver Diseases; Parenteral Nutrition; Soybean Oil; Ursodeoxycholic Acid | 2016 |
Obeticholic acid for the treatment of primary biliary cholangitis.
Topics: Animals; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; End Stage Liver Disease; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2016 |
Itch Management: Systemic Agents.
Topics: Amines; Analgesics; Analgesics, Opioid; Anion Exchange Resins; Antidepressive Agents; Aprepitant; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Histamine Antagonists; Humans; Morpholines; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Pregabalin; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; Rifampin; Thalidomide; Uremia; Ursodeoxycholic Acid | 2016 |
Cholestatic Itch Management.
Topics: Anion Exchange Resins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Humans; Lysophospholipids; Naltrexone; Narcotic Antagonists; Plasmapheresis; Pregnane X Receptor; Pruritus; Receptors, Steroid; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Ultraviolet Therapy; Ursodeoxycholic Acid | 2016 |
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
Topics: Animals; Cholestasis; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Liver Diseases; Metabolic Diseases; Ursodeoxycholic Acid | 2017 |
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
Topics: Animals; Bile Acids and Salts; Biological Transport, Active; Child; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Pregnancy; Ursodeoxycholic Acid | 2007 |
[Parenteral nutrition-associated liver disease].
Topics: Age Factors; Cholagogues and Choleretics; Cholestasis; Enteral Nutrition; Humans; Infant, Newborn; Infant, Premature; Liver Diseases; Parenteral Nutrition; Risk Factors; Short Bowel Syndrome; Time Factors; Ursodeoxycholic Acid | 2008 |
The chronic liver disease in patients with short bowel syndrome: etiology and treatment.
Topics: Anti-Bacterial Agents; Child; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Enteral Nutrition; Evidence-Based Medicine; Humans; Infant, Newborn; Infant, Premature; Intestine, Small; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Home; Practice Guidelines as Topic; Prognosis; Risk Factors; Sepsis; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
[Hepatobiliary transport of glutathione and its role in cholestasis].
Topics: Animals; Biological Transport; Cholestasis; Estrogens; Glutathione; Humans; Jaundice, Chronic Idiopathic; Liver; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Mutation; Phalloidine; Ursodeoxycholic Acid | 2009 |
[Pruritus associated with cholestasis].
Topics: Animals; Anion Exchange Resins; Cholestasis; Evidence-Based Medicine; Female; Gastrin-Releasing Peptide; Haplorhini; Humans; Male; Models, Neurological; Narcotic Antagonists; Neural Pathways; Opioid Peptides; Posterior Horn Cells; Pregnancy; Pregnancy Complications; Pruritus; Randomized Controlled Trials as Topic; Rifampin; Ursodeoxycholic Acid | 2010 |
Biliary physiology and disease: reflections of a physician-scientist.
Topics: Animals; Bile; Bile Acids and Salts; Cholestasis; Gallstones; Humans; Indocyanine Green; Liver; Recurrence; Ursodeoxycholic Acid | 2010 |
Pathogenesis of cholestatic liver disease and therapeutic approaches.
Topics: Animals; Apoptosis; Bile; Cholagogues and Choleretics; Cholestasis; Cytokines; Hepatocytes; Humans; Immunity, Cellular; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2010 |
Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus.
Topics: Cholestasis; Cholestyramine Resin; Humans; Lysophospholipids; Opioid Peptides; Plasmapheresis; Pruritus; Renal Dialysis; Rifampin; Sertraline; Sorption Detoxification; Ursodeoxycholic Acid | 2011 |
Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Canaliculi; Cholagogues and Choleretics; Cholestasis; Humans; Immunologic Factors; Mitochondria, Liver; Proto-Oncogene Proteins c-bcl-2; Ursodeoxycholic Acid | 2011 |
Scratching can reveal more than just an itch.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Function Tests; Midwifery; Nursing Diagnosis; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pruritus; Ursodeoxycholic Acid; Young Adult | 2011 |
Molecular targets for the treatment of fibrosing cholangiopathies.
Topics: Biliary Tract; Cholangitis, Sclerosing; Cholestasis; Hepatocytes; Humans; Immunosuppressive Agents; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2012 |
Current pharmacotherapy for cholestatic liver disease.
Topics: Cholangitis, Sclerosing; Cholestasis; Fibric Acids; Hepatitis, Autoimmune; Humans; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2012 |
Progressive familial intrahepatic cholestasis.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholestasis, Intrahepatic; Disease Progression; France; gamma-Glutamyltransferase; Genotype; Humans; Jaundice; Mutation; Prevalence; Prognosis; Pruritus; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion.
Topics: Anti-Bacterial Agents; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Equipment Failure; Humans; Randomized Controlled Trials as Topic; Stents; Ursodeoxycholic Acid | 2002 |
Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Topics: Cholagogues and Choleretics; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 2002 |
High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bile; Biliary Atresia; Chemotherapy, Adjuvant; Cholagogues and Choleretics; Cholestasis; Female; Humans; Infant; Infusions, Intravenous; Liver Transplantation; Male; Methylprednisolone Hemisuccinate; Portoenterostomy, Hepatic; Postoperative Complications; Prednisone; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2003 |
[Cholestasis. Recent diagnostic and therapeutic acquisitions].
Topics: Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cholestasis; Cholestasis, Intrahepatic; Clinical Trials as Topic; Endoscopy, Digestive System; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Magnetic Resonance Imaging; Meta-Analysis as Topic; Mutation; Risk Factors; Time Factors; Ursodeoxycholic Acid | 2003 |
[Treatment of cholestatic liver diseases].
Topics: Adrenal Cortex Hormones; Antimetabolites; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholestasis; Colchicine; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Stents; Ursodeoxycholic Acid | 2003 |
Bile duct disorders.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Bile Duct Diseases; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Humans; Radiotherapy; Ursodeoxycholic Acid | 2003 |
[The problem of biliary sludge].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bile; Cholagogues and Choleretics; Cholelithiasis; Cholestasis; Gallbladder; Humans; Sphincter of Oddi; Ultrasonography; Ursodeoxycholic Acid | 2003 |
[Treatment of primary biliary cirrhosis].
Topics: Antioxidants; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Colchicine; Enzyme Inhibitors; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Ursodeoxycholic Acid | 2003 |
[Bile acids in the process of canalicular bile formation].
Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Bile Canaliculi; Biological Transport, Active; Cholestasis; Gene Expression Regulation; Hepatocytes; Humans; Hydrophobic and Hydrophilic Interactions; Membrane Transport Proteins; Necrosis; Ursodeoxycholic Acid | 2003 |
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Topics: Cholestasis; Enterohepatic Circulation; Humans; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid | 2004 |
[Role of ursodeoxycholic acid in pediatric cholestatic disease].
Topics: Child; Cholagogues and Choleretics; Cholestasis; Humans; Ursodeoxycholic Acid | 2004 |
The management of primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Cholangitis, Sclerosing; Cholestasis; Humans; Immunosuppressive Agents; Methotrexate; Penicillamine; Ursodeoxycholic Acid | 1998 |
Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract; Biological Transport, Active; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Humans; Liver; Liver Cirrhosis, Biliary; Mice; Mutation; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2005 |
Review article: current management of primary sclerosing cholangitis.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Combined Modality Therapy; Endoscopy, Digestive System; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Failure; Liver Transplantation; Stents; Ursodeoxycholic Acid | 2005 |
New therapeutical indications of ursodeoxycholic acid.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Female; Hepatocytes; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Mitochondria, Liver; Oxidative Stress; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2005 |
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Topics: Animals; Bile; Cholagogues and Choleretics; Cholestasis; Humans; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Topics: Apoptosis; Bile Acids and Salts; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis; Liver Failure; Syndrome; Ursodeoxycholic Acid | 2006 |
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
Topics: Adrenal Cortex Hormones; Bacterial Infections; Bile; Bile Ducts; Cholestasis; Cytokines; Humans; Liver; Liver Diseases; Liver Transplantation; Nitric Oxide; Sepsis; Ursodeoxycholic Acid | 2006 |
Cholestasis and cholestatic syndromes.
Topics: Animals; Bile Acids and Salts; Biological Transport; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Humans; Prognosis; Syndrome; Ursodeoxycholic Acid | 2007 |
Parenteral nutrition related hepato-biliary disease in adults.
Topics: Adult; Anti-Bacterial Agents; Biliary Tract Diseases; Cholestasis; Fatty Liver; Gallstones; Hepatitis; Humans; Intestines; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Ursodeoxycholic Acid | 2007 |
Ursodiol in patients with parenteral nutrition-associated cholestasis.
Topics: Animals; Cholagogues and Choleretics; Cholestasis; Humans; Parenteral Nutrition; Ursodeoxycholic Acid | 2007 |
Managing liver dysfunction in parenteral nutrition.
Topics: Anti-Bacterial Agents; Cholestasis; Enteral Nutrition; Humans; Liver Diseases; Parenteral Nutrition; Risk Factors; Sepsis; Ursodeoxycholic Acid | 2007 |
[Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis].
Topics: Cholestasis; Female; Humans; Liver Diseases; Male; Neonatology; Parenteral Nutrition, Total; S-Adenosylmethionine; Ursodeoxycholic Acid | 2008 |
[Abnormal bile acids in obstructive jaundice].
Topics: Animals; Bile Acids and Salts; Cholestasis; Cholic Acid; Cholic Acids; Glycine; Humans; Rats; Taurine; Ursodeoxycholic Acid | 1984 |
Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children.
Topics: Adult; Bile Acids and Salts; Child; Cholestasis; Clinical Trials as Topic; Cystic Fibrosis; Female; Humans; Intestinal Absorption; Liver; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1995 |
Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions.
Topics: Adult; Bile; Bile Acids and Salts; Biliary Tract; Child; Cholestasis; Fasting; Humans; Infant; Parenteral Nutrition, Total; Ursodeoxycholic Acid | 1995 |
Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
Topics: Bile Acids and Salts; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Topics: Cholangitis, Sclerosing; Cholestasis; Humans; Ursodeoxycholic Acid | 1994 |
Therapy with ursodeoxycholic acid in cholestatic liver disease.
Topics: Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Postoperative Care; Pregnancy; Pregnancy Complications; Recurrence; Ursodeoxycholic Acid | 1993 |
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease.
Topics: Bile Acids and Salts; Cholestasis; Enterohepatic Circulation; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1993 |
Pharmacologic treatment of cholestasis.
Topics: Cholestasis; Cholestyramine Resin; Colestipol; Enzyme Induction; Humans; Pruritus; S-Adenosylmethionine; Ursodeoxycholic Acid | 1993 |
[Ursodeoxycholic acid in the treatment of cholestatic liver diseases].
Topics: Bile; Cholestasis; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1993 |
Pruritus associated with cholestasis. A review of pathogenesis and management.
Topics: Androgens; Antipruritics; Bile Acids and Salts; Cholestasis; Cholestyramine Resin; Female; Humans; Narcotic Antagonists; Plasmapheresis; Pregnancy; Pregnancy Complications; Propofol; Pruritus; Rifampin; Ultraviolet Therapy; Ursodeoxycholic Acid | 1994 |
Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
Topics: Administration, Oral; Bile Acids and Salts; Binding, Competitive; Cholestasis; Humans; Ileum; Intestinal Absorption; Solubility; Ursodeoxycholic Acid | 1995 |
[Bile acids and their therapeutic use in children].
Topics: Adult; Animals; Bile Acids and Salts; Cell Membrane; Child; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Cystic Fibrosis; Humans; Immunosuppressive Agents; Ursodeoxycholic Acid | 1995 |
[Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Female; Graft vs Host Disease; Hepatitis; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 1996 |
Drug-induced vanishing bile duct syndrome: response to ursodiol.
Topics: Antipsychotic Agents; Bile Duct Diseases; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Female; Humans; Liver Function Tests; Middle Aged; Prochlorperazine; Syndrome; Ursodeoxycholic Acid | 1996 |
[Mechanism of action of ursodeoxycholic acid in cholestatic liver diseases].
Topics: Cholagogues and Choleretics; Cholestasis; Humans; Ursodeoxycholic Acid | 1996 |
Pharmacological treatment of cholestasis.
Topics: Animals; Cholagogues and Choleretics; Cholestasis; Clinical Trials as Topic; Humans; Rats; S-Adenosylmethionine; Ursodeoxycholic Acid | 1996 |
Review article: the management of primary sclerosing cholangitis.
Topics: Chelating Agents; Cholangitis, Sclerosing; Cholestasis; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Prognosis; Ursodeoxycholic Acid | 1997 |
Parenteral nutrition-associated cholestasis.
Topics: Bacterial Translocation; Cholagogues and Choleretics; Cholecystokinin; Cholestasis; Humans; Infant, Newborn; Parenteral Nutrition, Total; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications.
Topics: Bile Acids and Salts; Chemical Phenomena; Chemistry, Physical; Cholestasis; Humans; Liver; Ursodeoxycholic Acid | 1998 |
Bile acid abnormalities in cholestatic liver diseases.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Humans; Liver Function Tests; Molecular Structure; Ursodeoxycholic Acid | 1999 |
Cholestasis of pregnancy.
Topics: Antipruritics; Cholestasis; Cholestyramine Resin; Dexamethasone; Female; Fetal Distress; Gastrointestinal Agents; Glucocorticoids; Humans; Pregnancy; Pregnancy Complications; Prevalence; Pruritus; S-Adenosylmethionine; Ursodeoxycholic Acid | 1999 |
Pruritus in pregnancy and obstetric cholestasis.
Topics: Cholagogues and Choleretics; Cholestasis; Female; Fetal Death; Humans; Infant Mortality; Infant, Newborn; Liver Function Tests; Pregnancy; Pregnancy Complications; Pruritus; Ursodeoxycholic Acid | 1999 |
New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis.
Topics: Animals; Cholecystokinin; Cholestasis; Humans; Methionine; Parenteral Nutrition, Total; Phytosterols; S-Adenosylmethionine; Ursodeoxycholic Acid | 1999 |
Mitochondrial membrane perturbations in cholestasis.
Topics: Animals; Apoptosis; Cholestasis; Humans; Intracellular Membranes; Mitochondria, Liver; Ursodeoxycholic Acid | 2000 |
Chronic cholestatic diseases.
Topics: Adult; Anti-Inflammatory Agents; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid therapy in hepatobiliary disease.
Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2000 |
Treatment of cholestasis and cholestatic disorders.
Topics: Cholagogues and Choleretics; Cholestasis; Chronic Disease; Humans; Ursodeoxycholic Acid | 2001 |
Interventions for treating cholestasis in pregnancy.
Topics: Charcoal; Cholestasis; Female; Galactans; Humans; Mannans; Plant Gums; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Ursodeoxycholic Acid | 2001 |
The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent.
Topics: Animals; Apoptosis; Bile Acids and Salts; Cholestasis; Humans; Mitochondria; Neurodegenerative Diseases; Neuroprotective Agents; Ursodeoxycholic Acid | 2001 |
Parenteral nutrition-associated liver complications in children.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bilirubin; Carnitine; Child; Cholestasis; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Parenteral Nutrition; Sepsis; Sincalide; Taurine; Ursodeoxycholic Acid | 2002 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Controlled Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant, Newborn; Liver Cirrhosis, Biliary; Male; Prednisolone; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 2002 |
[Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Topics: Adjuvants, Immunologic; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid for the treatment of cholestatic diseases.
Topics: Adult; Child; Cholangitis, Sclerosing; Cholestasis; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Transplantation; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1992 |
[Pathophysiology of cholestasis: correlation between bile acid metabolism and liver damage].
Topics: Animals; Bile Acids and Salts; Cholestasis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Ursodeoxycholic Acid | 1992 |
Advances in the therapy of cholestatic liver disease.
Topics: Cholestasis; Colchicine; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases.
Topics: Animals; Cholestasis; Chronic Disease; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Liver Cirrhosis, Biliary; Major Histocompatibility Complex; Ursodeoxycholic Acid | 1991 |
Ursodeoxycholic acid in chronic liver disease.
Topics: Animals; Cholestasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1991 |
[Ursodeoxycholic acid. Physical properties and hepatoprotective activity].
Topics: Animals; Bile Acids and Salts; Chemical Phenomena; Chemistry, Physical; Cholestasis; Cystic Fibrosis; Humans; Rats; Ursodeoxycholic Acid | 1991 |
Medical approaches to primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antipruritics; Azathioprine; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Humans; Mercaptopurine; Methotrexate; Penicillamine; Ursodeoxycholic Acid; Vitamins | 1991 |
26 trial(s) available for ursodeoxycholic acid and Bile Duct Obstruction
| Article | Year |
|---|---|
Effects of S-adenosyl-L-Methionine Combined with Ursodesoxycholic Acid on Serum Endotoxin, MMP-9 and IL-18 in Neonates with Cholestasis.
Topics: Cholestasis; Cholestasis, Intrahepatic; Endotoxins; Female; Humans; Infant, Newborn; Interleukin-18; Matrix Metalloproteinase 9; Methionine; Pregnancy; Pregnancy Complications; S-Adenosylmethionine; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic acid prevention on cholestasis associated with total parenteral nutrition in preterm infants: a randomized trial.
Topics: Cholestasis; Humans; Infant; Infant, Newborn; Infant, Premature; Parenteral Nutrition, Total; Prospective Studies; Retrospective Studies; Ursodeoxycholic Acid | 2022 |
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Topics: Adult; Alkaline Phosphatase; Cholangitis, Sclerosing; Cholestasis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Ursodeoxycholic Acid | 2017 |
Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry.
Topics: Carbon Radioisotopes; Cholestasis; Female; Humans; Infant; Infant, Newborn; Male; Mass Spectrometry; Models, Biological; Radioactive Tracers; Ursodeoxycholic Acid | 2014 |
[Approaches to the treatment of patients with climacteric disorders complicated with menopausal metabolic syndrome with cholestasis].
Topics: Body Mass Index; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Menopause; Metabolic Syndrome; Middle Aged; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2014 |
A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
Topics: Administration, Oral; Child Development; Cholestasis; Double-Blind Method; Erythromycin; Feeding and Eating Disorders; Feeding Behavior; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition; Prospective Studies; Risk Assessment; Ursodeoxycholic Acid; Weight Gain | 2012 |
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Topics: Adult; Bile Acids and Salts; Biliary Tract; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cytochrome P-450 CYP3A; Duodenum; Female; Gene Expression Profiling; Glycine; Humans; Inactivation, Metabolic; Intestinal Mucosa; Liver Cirrhosis, Biliary; Middle Aged; Taurine; Ursodeoxycholic Acid | 2012 |
Dexamethasone in the treatment of obstetric cholestasis: a case series.
Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Cholestasis; Dexamethasone; Female; Humans; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
Topics: Cholagogues and Choleretics; Cholestasis; Double-Blind Method; Fat Emulsions, Intravenous; Feces; Female; gamma-Glutamyltransferase; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Absorption; Male; Nutritional Status; Parenteral Nutrition, Total; Pilot Projects; Prospective Studies; Safety; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
Topics: Adult; Cholestasis; Drug Evaluation; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Pruritus; Treatment Outcome; Ursodeoxycholic Acid | 1995 |
Preventing biliary stent occlusion.
Topics: Bile Duct Neoplasms; Cholestasis; Humans; Stents; Ursodeoxycholic Acid | 1994 |
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin.
Topics: Administration, Oral; Bile Ducts; Cholestasis; Constriction, Pathologic; Drug Therapy, Combination; Humans; Norfloxacin; Stents; Ursodeoxycholic Acid | 1994 |
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bilirubin; Canada; Cholestasis; Cholesterol; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Transaminases; Ursodeoxycholic Acid | 1994 |
Effect of ursodeoxycholic acid treatment for cholestasis in liver transplant recipients.
Topics: Adolescent; Adult; Alanine Transaminase; Bilirubin; Child; Child, Preschool; Cholestasis; gamma-Glutamyltransferase; Humans; Liver Transplantation; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid therapy in pregnant women with cholestasis.
Topics: Adult; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome; Ursodeoxycholic Acid | 1996 |
Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cholagogues and Choleretics; Cholestasis; Drug Resistance; Female; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Pilot Projects; Recurrence; Ursodeoxycholic Acid | 1996 |
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Topics: Alkaline Phosphatase; Bile Acids and Salts; Cholestasis; Chronic Disease; Down-Regulation; Female; gamma-Glutamyltransferase; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Selenium Radioisotopes; Taurocholic Acid; Up-Regulation; Ursodeoxycholic Acid | 1996 |
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
Topics: Adolescent; Adult; Aged; Catheterization; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Combined Modality Therapy; Endoscopy, Digestive System; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
The effects of ursodeoxycholic acid in patients with severe obstructive jaundice after drainage procedure.
Topics: Aged; Cholestasis; Drainage; Female; Humans; Male; Middle Aged; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
Topics: Blood Proteins; Cell Degranulation; Cholestasis; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Eosinophils; Female; Hepatitis, Autoimmune; Hepatitis, Viral, Human; Humans; Immunohistochemistry; Leukocyte Count; Liver; Liver Cirrhosis, Biliary; Male; Placebos; Proteins; Radioimmunoassay; Ribonucleases; Ursodeoxycholic Acid | 1999 |
Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study.
Topics: Acute Disease; Adolescent; Adult; Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Hepatitis Antibodies; Hepatitis Viruses; Hepatitis, Viral, Human; Humans; Male; Middle Aged; Pilot Projects; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial.
Topics: Aged; Anti-Infective Agents; Cholagogues and Choleretics; Cholestasis; Female; Humans; Male; Norfloxacin; Prospective Studies; Stents; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Topics: Adult; Amniotic Fluid; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Dose-Response Relationship, Drug; Female; Fetal Blood; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pruritus; Ursodeoxycholic Acid | 2001 |
Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.
Topics: Bilirubin; Cholestasis; Chronic Disease; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases.
Topics: Animals; Cholestasis; Chronic Disease; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Liver Cirrhosis, Biliary; Major Histocompatibility Complex; Ursodeoxycholic Acid | 1991 |
A randomized clinical trial of oral ursodeoxycholic acid in obstructive jaundice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cholestasis; Clinical Trials as Topic; Creatinine; Deoxycholic Acid; Endotoxins; Female; Humans; Intraoperative Complications; Male; Middle Aged; Premedication; Random Allocation; Toxemia; Ursodeoxycholic Acid | 1986 |
234 other study(ies) available for ursodeoxycholic acid and Bile Duct Obstruction
| Article | Year |
|---|---|
Molecular cloning and characterization of the murine bile salt export pump.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Blotting, Western; Cell Line; Cell Membrane; Cholagogues and Choleretics; Cholestasis; Cloning, Molecular; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Rats; Sequence Homology, Amino Acid; Taurocholic Acid; Transfection | 2000 |
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.
Topics: Animals; Anticholesteremic Agents; Cell Line; Chenodeoxycholic Acid; Cholestasis; DNA-Binding Proteins; Humans; Ligands; Liver; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Transcription Factors | 2002 |
Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
Topics: Adult; Bile Acids and Salts; Cholangitis, Sclerosing; Cholestasis; Drug Therapy, Combination; Female; Fenofibrate; Glucuronides; Hepatocytes; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; PPAR alpha; Retrospective Studies; Treatment Outcome; Up-Regulation; Ursodeoxycholic Acid; Young Adult | 2021 |
Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Bilirubin; Child; Child, Preschool; Cholestasis; Cholestasis, Intrahepatic; gamma-Glutamyltransferase; Humans; Mutation; Pruritus; Retrospective Studies; Transaminases; Ursodeoxycholic Acid | 2022 |
Review of Medical Management of Primary Biliary Cholangitis.
Topics: Cholagogues and Choleretics; Cholestasis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2021 |
Primary biliary cholangitis first demonstrated in pregnancy: a case report.
Topics: Adult; Cesarean Section; Cholestasis; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Ursodeoxycholic Acid | 2022 |
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cholestasis; Inflammation; Interleukin-33; Lipopolysaccharides; Liver; Membrane Glycoproteins; Mice; Receptors, Immunologic; Triggering Receptor Expressed on Myeloid Cells-1; Ursodeoxycholic Acid | 2022 |
One case of arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome featuring an incomplete and mild phenotype.
Topics: Arthrogryposis; Bilirubin; Cholestasis; Female; Humans; Jaundice, Obstructive; Mutation; Phenotype; Pruritus; Renal Insufficiency; Ursodeoxycholic Acid; Vesicular Transport Proteins | 2022 |
Rolling stones: an instructive case of neonatal cholestasis.
Topics: Biliary Atresia; Choledocholithiasis; Cholestasis; Humans; Hyperbilirubinemia; Infant; Infant, Newborn; Infant, Newborn, Diseases; Jaundice, Neonatal; Liver Diseases; Male; Ursodeoxycholic Acid | 2022 |
Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
Topics: Animals; Bile Acids and Salts; Cholestasis; Female; Humans; Infant, Newborn; Liver Diseases; Male; Mice; Pregnancy; Ursodeoxycholic Acid | 2023 |
Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Bile Acids and Salts; Cholestasis; Fibrosis; Inflammation; Interleukin-6; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Pyridones; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2022 |
Resveratrol modulates the gut microbiota of cholestasis in pregnant rats.
Topics: Alanine; Alanine Transaminase; Animals; Aspartic Acid; Bile Acids and Salts; Cholestasis; Cholestasis, Intrahepatic; Dysbiosis; Ethinyl Estradiol; Female; Gastrointestinal Microbiome; Glutamates; Pregnancy; Pregnancy Complications; Rats; Resveratrol; RNA, Ribosomal, 16S; Ursodeoxycholic Acid | 2022 |
[Ursodeoxycholic acid: history and clinical implications].
Topics: Bicarbonates; Bile Acids and Salts; Chlorides; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Effect of ursodeoxycholic acid after self-expandable metal stent placement in malignant distal biliary obstruction: a propensity score-matched cohort analysis.
Topics: Cholestasis; Cohort Studies; Humans; Propensity Score; Retrospective Studies; Self Expandable Metallic Stents; Sewage; Stents; Ursodeoxycholic Acid | 2023 |
Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk.
Topics: Bile Acids and Salts; Cholestasis; Female; Humans; Infant, Newborn; Lactation; Milk, Human; Ursodeoxycholic Acid | 2022 |
L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
Topics: Bile Ducts, Intrahepatic; Bilirubin; Carbocysteine; Child; Cholestasis; Female; Humans; Jaundice; Syndrome; Ursodeoxycholic Acid | 2022 |
A novel therapy for hepatic cholestasis treatment-the combination of rosiglitazone and fenofibrate.
Topics: Animals; Cholestasis; Fenofibrate; Liver; Mice; Mice, Inbred C57BL; Necrosis; Rosiglitazone; Ursodeoxycholic Acid | 2023 |
Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis.
Topics: Cholangitis; Cholestasis; Evidence-Based Medicine; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2023 |
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives.
Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2023 |
Primary biliary cholangitis: Epidemiology, prognosis, and treatment.
Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Prognosis; Ursodeoxycholic Acid | 2023 |
Characterization of Metabolic Correlations of Ursodeoxycholic Acid with Other Bile Acid Species through In Vitro Sequential Metabolism and Isomer-Focused Identification.
Topics: Bile Acids and Salts; Cholestasis; Glucuronides; Humans; Mass Spectrometry; Ursodeoxycholic Acid | 2023 |
[Primary biliary cholangitis. Experience in 179 patients].
Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid; Young Adult | 2022 |
Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury.
Topics: Angiogenic Proteins; Animals; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cytokines; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Lacticaseibacillus rhamnosus; Liver; Male; Mice; Mice, Inbred C57BL; Pregnanolone; Probiotics; RNA-Binding Proteins; Signal Transduction; Ursodeoxycholic Acid | 2019 |
Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Topics: Apoptosis; Bile Acids and Salts; Bilirubin; Cell Line, Tumor; Cholestasis; Down-Regulation; Genetic Profile; Humans; Lithocholic Acid; Liver; Liver Diseases; Osteoblasts; Osteoporosis; Osteosarcoma; Up-Regulation; Ursodeoxycholic Acid | 2020 |
Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Cholestasis; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
The value of routine laboratory screening in the neonatal intensive care unit.
Topics: Alkaline Phosphatase; Anemia; Bilirubin; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cholagogues and Choleretics; Cholestasis; Diagnostic Tests, Routine; Erythrocyte Transfusion; Female; Gestational Age; Health Care Costs; Health Expenditures; Hematocrit; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Liver Function Tests; Male; Mass Screening; Parenteral Nutrition, Total; Patient Selection; Retrospective Studies; Ursodeoxycholic Acid; Vitamin D | 2020 |
Refractory pruritus from malignant cholestasis: management.
Topics: Cholestasis; Cholestyramine Resin; Humans; Pruritus; Ursodeoxycholic Acid | 2023 |
FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
Topics: Autophagosomes; Autophagy; Autophagy-Related Proteins; Chenodeoxycholic Acid; Cholestasis; Cytotoxins; Gene Knockdown Techniques; Hep G2 Cells; Humans; Liver; Lysosomes; Receptors, Cytoplasmic and Nuclear; Retrospective Studies; Signal Transduction; Transfection; Ursodeoxycholic Acid | 2020 |
Does ursodeoxycholic acid have a role in the treatment of women with intrahepatic (obstetric) cholestasis of pregnancy anymore?
Topics: Cholestasis; Female; Humans; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study.
Topics: Case-Control Studies; Cholestasis; Egypt; Female; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Postoperative Complications; Retrospective Studies; Severity of Illness Index; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.
Topics: Cholagogues and Choleretics; Cholestasis; Cholestasis, Intrahepatic; Female; Humans; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2021 |
NISCH syndrome: An extremely rare cause of neonatal cholestasis.
Topics: Alopecia; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Claudin-1; Female; Genetic Testing; Humans; Hyperbilirubinemia; Ichthyosis; Infant, Newborn; Leukocyte Disorders; Liver Function Tests; Mutation; Transaminases; Ursodeoxycholic Acid; Vitamins | 2020 |
Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
Topics: Bile Ducts; Cholangitis, Sclerosing; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2020 |
Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Bile Canaliculi; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Claudin-1; Cytochrome P450 Family 2; Cytoskeletal Proteins; Epithelial Cells; Female; Fibrosis; Genetic Predisposition to Disease; Hepatocytes; Male; Membrane Proteins; Mice; Mice, Knockout; Mutation; Oxazoles; Permeability; Protective Factors; RNA, Messenger; Steroid Hydroxylases; Tight Junctions; Ursodeoxycholic Acid; Zonula Occludens-2 Protein | 2021 |
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
Topics: Autoantibodies; Cholestasis; Diabetes Mellitus, Type 2; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Ursodeoxycholic Acid | 2022 |
Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
Topics: Apoptosis; Autoimmune Diseases; Bile Acids and Salts; Carcinoma, Hepatocellular; Caspase 3; Cholangitis, Sclerosing; Cholestanetriol 26-Monooxygenase; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Dietary Supplements; Down-Regulation; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fatty Acids, Omega-3; Gene Expression; Hep G2 Cells; Humans; Inflammation; Liver; Liver Cirrhosis, Biliary; Liver Diseases; THP-1 Cells; Ursodeoxycholic Acid | 2021 |
Primary Biliary Cholangitis: advances in management and treatment of the disease.
Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Ursodeoxycholic Acid | 2017 |
Primary sclerosing cholangitis: Ursodeoxycholic acid derivative: safe and effective.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Humans; Ursodeoxycholic Acid | 2017 |
24-Norursodeoxycholic acid in patients with primary sclerosing cholangitis: A new "urso saga" on the horizon?
Topics: Cholangitis, Sclerosing; Cholestasis; Humans; Ursodeoxycholic Acid | 2017 |
A case of Alagille syndrome presenting with chronic cholestasis in an adult.
Topics: Adult; Alagille Syndrome; Alkaline Phosphatase; Cholestasis; gamma-Glutamyltransferase; Humans; Liver; Male; Tomography, X-Ray Computed; Ultrasonography; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis.
Topics: Animals; Calcium; Calcium Channels, T-Type; Cholestasis; Electrophysiological Phenomena; Female; Fetal Heart; Heart Ventricles; Humans; Myocytes, Cardiac; Pregnancy; Rats; Taurocholic Acid; Ursodeoxycholic Acid | 2017 |
Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis.
Topics: Aged; Autoantibodies; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Colitis, Ulcerative; Diagnosis, Differential; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Treatment Outcome; Ursodeoxycholic Acid | 2017 |
Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?
Topics: Adult; Aged; Canada; Cholestasis; Female; Humans; Immunomodulation; Inuit; Male; Middle Aged; Ursodeoxycholic Acid | 2017 |
Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Drug Therapy, Combination; Female; Hepatocytes; Liver; Liver Cirrhosis; Malondialdehyde; Peroxidase; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Silybum marianum; Stem Cells; Ursodeoxycholic Acid | 2017 |
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.
Topics: Animals; Cholestasis; Cyclooxygenase 2; Estrogens; Ethinyl Estradiol; Hep G2 Cells; Humans; Interleukin-1beta; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Prodrugs; Rats; Rats, Wistar; Solubility; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2018 |
Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Cell Survival; Cells, Cultured; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Cytochrome P450 Family 7; Dexamethasone; Down-Regulation; Glucosides; Glucuronosyltransferase; Humans; Hydrolyzable Tannins; Isoxazoles; Liver; Male; Organic Anion Transporters, Sodium-Dependent; Pregnenediones; Primary Cell Culture; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Steroid Hydroxylases; Sulfotransferases; Symporters; Up-Regulation; Ursodeoxycholic Acid | 2018 |
Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease.
Topics: beta Carotene; Child; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Diagnosis, Differential; Humans; Male; Photosensitivity Disorders; Protoporphyria, Erythropoietic; Provitamins; Pruritus; Ursodeoxycholic Acid | 2018 |
Autoimmune Pancreatitis and Ulcerative Rectocolitis in an Adolescent.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Biopsy; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholestasis; Diagnosis, Differential; Humans; Immunoglobulin G; Immunosuppressive Agents; Liver Cirrhosis; Male; Pancreatic Neoplasms; Pancreatitis; Proctocolitis; Ultrasonography; Ursodeoxycholic Acid | 2018 |
Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes.
Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Echocardiography; Electrocardiography; End Stage Liver Disease; Female; Humans; Incidence; Infant; Length of Stay; Liver Cirrhosis; Liver Transplantation; Male; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression.
Topics: Administration, Oral; Animals; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cholestasis; Down-Regulation; Drug Administration Schedule; Ethinyl Estradiol; Male; Methotrexate; Multidrug Resistance-Associated Protein 2; Rats; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment.
Topics: Animals; Body Weight; Cholestasis; Diet, Western; Fathers; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; Obesity; Ursodeoxycholic Acid | 2019 |
How best to manage chronic cholestasis.
Topics: Adult; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Disease Management; Family Practice; Female; Humans; Practice Guidelines as Topic; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis.
Topics: Biopsy; Cholagogues and Choleretics; Cholestasis; Clinical Decision-Making; Combined Modality Therapy; Female; Humans; Infant, Newborn; Liver; Male; Parenteral Nutrition, Total; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Male; Medication Adherence; Middle Aged; Prospective Studies; Ursodeoxycholic Acid; Young Adult | 2019 |
[Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid | 2019 |
Cholestasis affects enteral tolerance and prospective weight gain in the NICU.
Topics: Bilirubin; Birth Weight; Cholagogues and Choleretics; Cholestasis; Digestive System Surgical Procedures; Disease Progression; Fat Emulsions, Intravenous; Female; Fibrosis; Fish Oils; Humans; Hyperbilirubinemia; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Parenteral Nutrition; Postoperative Complications; Prognosis; Retrospective Studies; Ursodeoxycholic Acid; Weight Gain | 2019 |
Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Topics: Alkaline Phosphatase; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Hepatocytes; Lipopolysaccharides; Liver; Male; Rats; Rats, Wistar; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Cholagogues and Choleretics; Cholestasis; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunoglobulin M; Liver Cirrhosis, Biliary; Mitochondrial Proteins; Prednisolone; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
Topics: Bilirubin; Calcification, Physiologic; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cholestasis; Humans; Jaundice; Lithocholic Acid; Osteoblasts; Osteoporosis; Statistics, Nonparametric; Ursodeoxycholic Acid | 2013 |
Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis.
Topics: Acute Disease; Alanine Transaminase; Analysis of Variance; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Cholestasis; Dexamethasone; Disease Models, Animal; Glucosides; Hydrolyzable Tannins; Liver; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Ursodeoxycholic Acid | 2013 |
Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Bile Canaliculi; Biological Transport; Cholestasis; Diet; Disease Models, Animal; Gene Expression Regulation; Infusions, Intravenous; Liver; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins; RNA, Messenger; Taurochenodeoxycholic Acid; Time Factors; Ursodeoxycholic Acid | 2013 |
Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.
Topics: Animals; Bile Acids and Salts; Cholestasis; Common Bile Duct; Disease Models, Animal; Kidney Diseases; Kidney Tubules; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephritis, Interstitial; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2013 |
[Effects of ursodeoxycholic acid on mRNA expression of MDR3 and FXR in infants with cholestatic hepatitis].
Topics: ATP Binding Cassette Transporter, Subfamily B; Cholestasis; Female; Gene Expression Regulation; Hepatitis; Humans; Infant; Male; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Ursodeoxycholic Acid | 2013 |
Ursodeoxycholic acid induced generalized fixed drug eruption.
Topics: Anti-Inflammatory Agents; Cetirizine; Cholestasis; Drug Eruptions; Gallstones; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Mometasone Furoate; Pregnadienediols; Skin; Ursodeoxycholic Acid | 2014 |
Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Bile Ducts; Cholagogues and Choleretics; Cholestasis; Hep G2 Cells; Hepatocytes; Humans; Ligation; Liver; MAP Kinase Signaling System; Mice; Proto-Oncogene Proteins c-met; Transforming Growth Factor alpha; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2013 |
Alagille syndrome: experience of a tertiary care center in North India.
Topics: Alagille Syndrome; Calcium, Dietary; Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Energy Intake; Female; Humans; India; Infant; Male; Prognosis; Pruritus; Recommended Dietary Allowances; Rifampin; Tertiary Care Centers; Triglycerides; Ursodeoxycholic Acid; Vitamins | 2014 |
All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Topics: 1-Naphthylisothiocyanate; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cell Proliferation; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Liver; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Tretinoin; Ursodeoxycholic Acid | 2014 |
[Biliary sludge: diagnosis and treatment at an outpatient's clinic].
Topics: Ambulatory Care; Bile; Cholagogues and Choleretics; Cholestasis; Female; Gallbladder; Humans; Male; Middle Aged; Ultrasonography; Ursodeoxycholic Acid | 2013 |
Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cholestasis; Glycochenodeoxycholic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Liver; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylethanolamines; Phosphorylation; Up-Regulation; Ursodeoxycholic Acid | 2015 |
Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Bleomycin; Cholagogues and Choleretics; Cholestasis; Doxorubicin; Hodgkin Disease; Humans; Immunocompromised Host; Male; Neutropenia; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Ursodeoxycholic acid alleviates cholestasis-induced histophysiological alterations in the male reproductive system of bile duct-ligated rats.
Topics: Animals; Body Weight; Cholestasis; Epididymis; Ligation; Liver; Male; Nitric Oxide; Organ Size; Prostate-Specific Antigen; Rats; Rats, Wistar; Testis; Ursodeoxycholic Acid | 2014 |
Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
Topics: Bilirubin; Cholagogues and Choleretics; Cholestasis; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Parenteral Nutrition; Retrospective Studies; Sepsis; Time Factors; Ursodeoxycholic Acid; Withholding Treatment | 2014 |
Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change?
Topics: Biliary Tract; Cholagogues and Choleretics; Cholestasis; Humans; Hypnotics and Sedatives; Infant; Liver; Perfusion Imaging; Phenobarbital; Ursodeoxycholic Acid | 2015 |
Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation.
Topics: Cholagogues and Choleretics; Cholestasis; Fatty Liver, Alcoholic; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prednisone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.
Topics: Biliary Tract; Cholestasis; Female; Humans; Infant; Infant, Newborn; Liver; Male; Phenobarbital; Radionuclide Imaging; Ursodeoxycholic Acid | 2015 |
[Morpho-functional changes in the liver and the possibility of their correction in the offspring of rats with cholestasis].
Topics: Animals; Cholestasis; Female; Hepatocytes; Humans; Liver; Lysosomes; Maternal-Fetal Relations; NADH Dehydrogenase; Pregnancy; Rats; Succinate Dehydrogenase; Ursodeoxycholic Acid | 2015 |
Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid.
Topics: Animals; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Immunohistochemistry; Male; Rats, Wistar; Spermatogenesis; Testicular Diseases; Testis; Ursodeoxycholic Acid | 2015 |
Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
Topics: Biliary Tract; Cholestasis; Female; Humans; Liver; Male; Phenobarbital; Radionuclide Imaging; Ursodeoxycholic Acid | 2015 |
Drug-augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: What does the evidence point to?
Topics: Biliary Tract; Cholestasis; Female; Humans; Liver; Male; Phenobarbital; Radionuclide Imaging; Ursodeoxycholic Acid | 2015 |
Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; CHO Cells; Cholestasis; Ciprofloxacin; Cricetulus; Disease Models, Animal; Female; Fluorine Radioisotopes; Liver; Mice, Knockout; Multidrug Resistance-Associated Proteins; Organ Specificity; Positron-Emission Tomography; Substrate Specificity; Tissue Distribution; Ursodeoxycholic Acid | 2016 |
UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Topics: Adenylate Kinase; Animals; Carrier Proteins; Cells, Cultured; Chenodeoxycholic Acid; Cholestasis; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activation; Ethinyl Estradiol; Female; Male; Membrane Glycoproteins; Phosphorylation; Pregnancy; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 2016 |
Chronic Pruritus in an 18-Month-Old Male Infant Due to Anicteric Cholestasis.
Topics: ATP Binding Cassette Transporter, Subfamily B; Biopsy; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Humans; Infant; Liver; Male; Pruritus; Treatment Outcome; Ursodeoxycholic Acid | 2017 |
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Topics: Animals; Bile Acids and Salts; Cholestasis; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Ligation; Lipocalin-2; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Ursodeoxycholic Acid | 2017 |
Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy.
Topics: Animals; Antioxidants; Ascorbic Acid; Cell Line, Tumor; Cholestasis; Female; Humans; Male; Maternal-Fetal Exchange; Organic Anion Transporters, Sodium-Dependent; Oxidative Stress; Oxidoreductases Acting on CH-CH Group Donors; Pregnancy; Pregnancy Complications; Rats; Rats, Wistar; Reactive Oxygen Species; Ursodeoxycholic Acid | 2008 |
Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase.
Topics: Amino Acid Sequence; Cell Line; Cholestasis; Cloning, Molecular; Glucose; Glucuronosyltransferase; Humans; Kidney; Kinetics; Liver; Models, Biological; Molecular Sequence Data; N-Acetylglucosaminyltransferases; Sequence Homology, Amino Acid; Uridine Diphosphate; Ursodeoxycholic Acid | 2008 |
Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: review of a historical cohort.
Topics: Bile Ducts, Intrahepatic; Cholestasis; Female; Hepatitis; Humans; Infant, Newborn; Male; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
Elevated bile acids associated with acute hepatitis A infection in the third trimester of pregnancy.
Topics: Bile Acids and Salts; Cesarean Section; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Female; Hepatitis A; Humans; Infant, Newborn; Oligohydramnios; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Ursodeoxycholic Acid; Young Adult | 2009 |
Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications.
Topics: Animals; Cholagogues and Choleretics; Cholestasis; Glutathione; Male; Mice; Mice, Inbred C57BL; S-Adenosylmethionine; Ursodeoxycholic Acid | 2009 |
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bile; Candida; Child; Cholangitis, Sclerosing; Cholestasis; Female; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid | 2009 |
[Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
Topics: Cholagogues and Choleretics; Cholestasis; Female; Humans; Infant, Newborn; Male; Parenteral Nutrition; Retrospective Studies; Time Factors; Ursodeoxycholic Acid | 2009 |
Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis.
Topics: Adolescent; Adult; Cholagogues and Choleretics; Cholestasis; Double-Blind Method; Female; Humans; Labor, Induced; Middle Aged; Pilot Projects; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Research Design; United Kingdom; Ursodeoxycholic Acid | 2009 |
Neonatal cholestasis: differentiation of biliary atresia from neonatal hepatitis in a developing country.
Topics: Biliary Atresia; Biopsy; Chi-Square Distribution; Cholagogues and Choleretics; Cholangiography; Cholestasis; Developing Countries; Diagnosis, Differential; Feces; Female; Hepatitis; Humans; India; Infant, Newborn; Liver; Male; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Ursodeoxycholic Acid | 2009 |
Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis.
Topics: Adult; Aged; Amyloidosis; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 2009 |
Cholestasis in neonatal intensive care unit: incidence, aetiology and management.
Topics: Bilirubin; Cholestasis; Female; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Italy; Logistic Models; Male; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis.
Topics: Child, Preschool; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Female; Fibrosis; Humans; Jaundice, Obstructive; Pancreatitis; Positron-Emission Tomography; Ursodeoxycholic Acid; Victoria | 2009 |
Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice.
Topics: Animals; Cell Line, Tumor; Cholestasis; Glutamate-Cysteine Ligase; Glutathione; Humans; Lithocholic Acid; MafG Transcription Factor; MafK Transcription Factor; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Promoter Regions, Genetic; Repressor Proteins; Response Elements; S-Adenosylmethionine; Ursodeoxycholic Acid | 2010 |
Atorvastatin-induced prolonged cholestasis with bile duct damage.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Dyslipidemias; Heptanoic Acids; Humans; Male; Pyrroles; Ursodeoxycholic Acid | 2010 |
Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Gene Expression; Genes, Reporter; Genetic Variation; Glucuronosyltransferase; Hep G2 Cells; Humans; Lithocholic Acid; Luciferases; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Transcriptional Activation; Ursodeoxycholic Acid; Xenobiotics | 2010 |
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Cholangitis, Sclerosing; Cholestasis; Colorectal Neoplasms; Comorbidity; Female; Follow-Up Studies; Gallbladder Neoplasms; Humans; Incidence; Inflammatory Bowel Diseases; Kaplan-Meier Estimate; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Survival Rate; Ursodeoxycholic Acid; Young Adult | 2010 |
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholangitis; Cholestasis; Chromatography, Gas; Hepatoblastoma; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Rats; Rats, Sprague-Dawley; Taurine; Taurolithocholic Acid; Ursodeoxycholic Acid | 2010 |
Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Austria; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Female; Humans; Male; Middle Aged; Pruritus; Retrospective Studies; Risk Factors; Treatment Outcome; Up-Regulation; Ursodeoxycholic Acid | 2011 |
Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antiviral Agents; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Clavulanic Acid; Epstein-Barr Virus Infections; Female; Hepatitis; Humans; Immunoglobulins; Steroids; Stevens-Johnson Syndrome; Ursodeoxycholic Acid | 2011 |
Delayed postnatal presentation of biliary atresia in 2 premature neonates.
Topics: Bile Ducts; Biliary Atresia; Bilirubin; Child Development; Cholagogues and Choleretics; Cholestasis; Color; Feces; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Jaundice, Neonatal; Portoenterostomy, Hepatic; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2011 |
Cholestatic hepatitis related to amoxicillin.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestasis; Female; Humans; Liver Function Tests; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
[No complaints, but constantly elevated cholestatic serum liver tests].
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Autoantibodies; Cholangitis, Sclerosing; Cholestasis; Diagnosis, Differential; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Mitochondria, Liver; Ultrasonography; Ursodeoxycholic Acid | 2011 |
Two-year experience of obstetric cholestasis: outcome and management.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholestasis; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Patient Admission; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Ursodeoxycholic Acid | 2011 |
A contemporary analysis of parenteral nutrition-associated liver disease in surgical infants.
Topics: Cholestasis; Diagnosis-Related Groups; Female; Humans; Hyperbilirubinemia; Incidence; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Logistic Models; Male; Nutritional Support; Parenteral Nutrition; Postoperative Complications; Prognosis; Retrospective Studies; Ursodeoxycholic Acid | 2011 |
Prurigo nodularis as the first manifestation of a chronic autoimmune cholestatic hepatitis.
Topics: Alkaline Phosphatase; Antibodies, Antinuclear; Azathioprine; Cholestasis; Cyclosporine; Dermatologic Agents; Female; gamma-Glutamyltransferase; Hepatitis, Autoimmune; Humans; Middle Aged; Prurigo; Ursodeoxycholic Acid | 2011 |
Neonatal jaundice.
Topics: Biliary Atresia; Bilirubin; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Diagnostic Techniques, Digestive System; Diet; Energy Intake; Hepatitis; Hepatomegaly; Humans; Incidence; Infant, Newborn; Jaundice, Neonatal; Prognosis; Splenomegaly; Syndrome; Ursodeoxycholic Acid; Vitamins | 2012 |
Does ursodeoxycholic acid exert a protective effect on liver grafts in orthotopic liver transplantation?
Topics: Cholagogues and Choleretics; Cholestasis; Humans; Liver Transplantation; Postoperative Care; Transplantation, Homologous; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid: increased mortality.
Topics: Cholagogues and Choleretics; Cholestasis; Chronic Disease; Digestive System Diseases; Drug Administration Schedule; Evidence-Based Medicine; Humans; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Low phospholipid-associated cholestasis and cholelithiasis.
Topics: Age Distribution; ATP Binding Cassette Transporter, Subfamily B; Cholagogues and Choleretics; Cholelithiasis; Cholestasis; Diagnosis, Differential; Female; Genotype; Humans; Mutation; Phenotype; Phospholipids; Pregnancy; Pregnancy Complications; Risk Factors; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats.
Topics: Animals; Antioxidants; Artemisia; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Liver Cirrhosis; Liver Function Tests; Male; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 2013 |
Differential effects of norUDCA and UDCA in obstructive cholestasis in mice.
Topics: Adenosine Triphosphate; Animals; Bicarbonates; Cholestasis; Humans; Male; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid | 2013 |
Prevention and treatment of intestinal failure-associated liver disease in children.
Topics: Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Liver; Humans; Intestinal Diseases; Liver Cirrhosis; Liver Diseases; Parenteral Nutrition; Ursodeoxycholic Acid | 2012 |
Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Biological Transport, Active; Carrier Proteins; Cholestasis; Estradiol Congeners; Ethinyl Estradiol; Glutathione; Hydroxysteroid Dehydrogenases; Immunoblotting; Male; Membrane Glycoproteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters, Sodium-Dependent; Rats; Rats, Sprague-Dawley; RNA, Messenger; Symporters; Ursodeoxycholic Acid | 2002 |
[Clinical analysis of 22 patients with primary biliary cirrhosis].
Topics: Alkaline Phosphatase; Bilirubin; Cholestasis; Female; Hepatomegaly; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 2002 |
Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
Topics: Anion Exchange Resins; Antipruritics; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Cholic Acid; Epichlorohydrin; Humans; Imidazoles; Pruritus; Resins, Synthetic; Ursodeoxycholic Acid | 2002 |
Mitochondrially mediated synergistic cell killing by bile acids.
Topics: Adenine Nucleotides; Animals; Bile Acids and Salts; Cell Survival; Chenodeoxycholic Acid; Cholestasis; Drug Synergism; Hepatocytes; Ion Channels; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Rats; Rats, Sprague-Dawley; Rhodamines; Time Factors; Ursodeoxycholic Acid | 2003 |
Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
Topics: Adolescent; Child; Cholagogues and Choleretics; Cholestasis; Female; Humans; Hyperbilirubinemia; Infant; Intensive Care Units, Pediatric; Male; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway.
Topics: Animals; Antipyrine; Cell Membrane; Cholestasis; DNA Primers; Female; Gene Expression; Glycocholic Acid; Kinetics; Liver; Maternal-Fetal Exchange; Placenta; Pregnancy; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ursodeoxycholic Acid | 2003 |
Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Topics: Animals; Bile; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Estrogens; Ethinyl Estradiol; Hepatocytes; Kinetics; Lipids; Liver; Male; Microsomes, Liver; Rats; Rats, Wistar; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2003 |
Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Bile Acids and Salts; Blotting, Northern; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Fluorescent Antibody Technique; Gene Expression; Hepatitis; Liver; Male; Membrane Transport Proteins; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Rats; Rats, Wistar; RNA, Messenger; Solute Carrier Organic Anion Transporter Family Member 1B3; Symporters; Ursodeoxycholic Acid | 2003 |
Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Homeostasis; Humans; Ileum; Ursodeoxycholic Acid | 2003 |
Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment.
Topics: Alanine Transaminase; Cholagogues and Choleretics; Cholestasis; Female; gamma-Glutamyltransferase; Humans; Incidence; Liver Function Tests; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid | 2003 |
An unusual combination of relapsing and cholestatic hepatitis A in childhood.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Cholestasis; Hepatitis A; Humans; Male; Ursodeoxycholic Acid | 2003 |
Extreme short bowel syndrome in a full-term neonate--a case report.
Topics: Anastomosis, Surgical; Breast Feeding; Cholagogues and Choleretics; Cholestasis; Diarrhea, Infantile; Humans; Infant, Newborn; Intestinal Volvulus; Intestines; Liver Function Tests; Male; Necrosis; Parenteral Nutrition; Short Bowel Syndrome; Steatorrhea; Ursodeoxycholic Acid | 2003 |
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Carrier Proteins; Cholestasis; Cytoprotection; DNA-Binding Proteins; Isocyanates; Isoxazoles; Male; Membrane Transport Proteins; Naphthalenes; Organic Anion Transporters, Sodium-Dependent; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Steroid 12-alpha-Hydroxylase; Symporters; Taurine; Transcription Factors; Ursodeoxycholic Acid | 2003 |
Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
Topics: Animals; Cardiolipins; Cholestasis; Chronic Disease; Cystathionine gamma-Lyase; Glutamate-Cysteine Ligase; Glutathione; Hepatocytes; Liver; Liver Cirrhosis, Biliary; Male; Membrane Potentials; Mitochondria; Oxidation-Reduction; Oxidative Stress; Peroxides; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2004 |
Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestasis; Female; Humans; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Ursodeoxycholic Acid | 2004 |
Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
Topics: Bilirubin; Birth Weight; Case-Control Studies; Cholestasis; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Parenteral Nutrition; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Topics: Animals; Animals, Newborn; Bile; Bile Acids and Salts; Bile Canaliculi; Carrier Proteins; Cell Membrane; Cholagogues and Choleretics; Cholestasis; Cholesterol; DNA Primers; Female; Gene Expression Regulation, Enzymologic; Membrane Fluidity; Microscopy, Electron, Transmission; Phospholipids; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Ursodeoxycholic Acid | 2005 |
Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Topics: Animals; Bile; Cholestasis; Ethinyl Estradiol; Hepatocytes; Male; Mitochondrial Proteins; Protein Transport; Rats; Rats, Wistar; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Ursodeoxycholic Acid | 2005 |
Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; bcl-2-Associated X Protein; Bile Acids and Salts; Biomarkers; Caspase 3; Caspases; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Enzyme Precursors; Female; Liver; Maternal-Fetal Exchange; Oxidative Stress; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2005 |
Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid.
Topics: Animals; Apoptosis; Cell Nucleus; Cholestasis; Female; Lipid Peroxidation; Oxidative Stress; Placenta; Pregnancy; Pregnancy Complications; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Topics: Administration, Oral; Cholagogues and Choleretics; Cholestasis; Female; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Parenteral Nutrition, Total; Retrospective Studies; Ursodeoxycholic Acid | 2006 |
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Topics: Animals; Apoptosis; Bile Ducts; Calcium; Cell Proliferation; Cholestasis; Cytoprotection; Disease Models, Animal; Egtazic Acid; Enzyme Activation; Epithelium; Ligation; Male; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C-alpha; Rats; Rats, Inbred F344; Signal Transduction; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid; Vagotomy | 2006 |
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Topics: Animals; Bile; Bile Ducts; Cholanes; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Chromatography, High Pressure Liquid; Deoxycholic Acid; Dose-Response Relationship, Drug; Ethinyl Estradiol; Gas Chromatography-Mass Spectrometry; Male; Micelles; Molecular Structure; Phospholipids; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid 12-alpha-Hydroxylase; Steroids, Fluorinated; Ursodeoxycholic Acid | 2006 |
Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Topics: Animals; Animals, Newborn; Bile Acids and Salts; Carrier Proteins; Cholestasis; Female; Fetus; Gene Expression Regulation; Liver; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ursodeoxycholic Acid | 2006 |
Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
Topics: Cholagogues and Choleretics; Cholestasis; Humans; Infant; Infant, Newborn; Intestinal Diseases; Parenteral Nutrition; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Obstetric cholestasis characterized by extremely elevated serum transaminases.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholestasis; Female; Humans; Pregnancy; Pregnancy Complications; Pruritus; Ursodeoxycholic Acid | 2007 |
Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Ducts; Cells, Cultured; Cholestasis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression Regulation; Hypoxia; Ischemia; Liver; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Dependent; Rats; Rats, Wistar; Symporters; Ursodeoxycholic Acid; Vascular Endothelial Growth Factor A | 2007 |
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles; Single-Blind Method; Transaminases; Ursodeoxycholic Acid | 2007 |
Anabolic-androgenic steroids and liver injury.
Topics: Adult; Anabolic Agents; Androgens; Chemical and Drug Induced Liver Injury; Cholestasis; Hepatomegaly; Humans; Liver Diseases; Male; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
Prolonged cholestasis following successful removal of common bile duct stones: beware patients on estrogen therapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Estrogen Replacement Therapy; Estrogens; Female; Gallstones; Humans; Postoperative Complications; Ursodeoxycholic Acid | 2007 |
Glycoursodeoxycholate is as effective as tauroursodeoxycholate in preventing the taurocholate-induced cholestasis in the rat.
Topics: Animals; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Deoxycholic Acid; Drug Evaluation, Preclinical; Rats; Secretory Rate; Taurochenodeoxycholic Acid; Taurocholic Acid; Ursodeoxycholic Acid | 1983 |
Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide.
Topics: Abdomen; Abdominal Pain; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cardiac Surgical Procedures; Cholestasis; Eating; Humans; Hyperbilirubinemia; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Liver Failure; Parenteral Nutrition, Total; Sincalide; Survival Rate; Ursodeoxycholic Acid | 1995 |
Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Topics: Alkaline Phosphatase; Animals; Bile; Bile Acids and Salts; Bile Canaliculi; Cell Fractionation; Cell Membrane; Cholestasis; Ethinyl Estradiol; gamma-Glutamyltransferase; Liver; Male; Rats; Rats, Wistar; Secretory Rate; Ursodeoxycholic Acid | 1995 |
Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid.
Topics: Adult; Cholestasis; Female; Fetal Death; Humans; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Pruritus; Ursodeoxycholic Acid | 1995 |
Lipoprotein abnormalities in two children with minimal biliary excretion.
Topics: Alagille Syndrome; Bile Acids and Salts; Bile Duct Diseases; Child, Preschool; Cholestasis; Cholesterol; Humans; Infant; Lipid Metabolism; Lipids; Lipoprotein-X; Lipoproteins; Male; Ursodeoxycholic Acid | 1995 |
Effect of cholestasis and bile acids on interferon-induced 2',5'-adenylate synthetase and NK cell activities.
Topics: 2',5'-Oligoadenylate Synthetase; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Enzyme Induction; Humans; Interferon-alpha; Killer Cells, Natural; Lymphocytes; Male; Rats; Rats, Wistar; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid for the treatment of flucloxacillin-associated cholestasis.
Topics: Aged; Cholestasis; Floxacillin; Humans; Male; Middle Aged; Ursodeoxycholic Acid | 1995 |
Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Topics: Analysis of Variance; Animals; Cholestasis; Drug Evaluation, Preclinical; Hemodynamics; Hypertension, Portal; Kidney; Male; Random Allocation; Rats; Rats, Wistar; Ursodeoxycholic Acid | 1995 |
[Benign biliary stricture treated successfully by implantable injection port--report of a case].
Topics: Cholestasis; Constriction, Pathologic; Drainage; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Ursodeoxycholic Acid | 1994 |
[Nodular regenerative hyperplasia of the liver and Turner syndrome].
Topics: Adult; Cholestasis; Female; Humans; Hyperplasia; Liver; Turner Syndrome; Ursodeoxycholic Acid | 1994 |
Preventing biliary stent occlusion.
Topics: Bacterial Infections; Cholestasis; Drug Therapy, Combination; Humans; Norfloxacin; Stents; Ursodeoxycholic Acid | 1994 |
Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
Topics: Adult; Aged; Cholestasis; Female; Humans; Male; Middle Aged; Parenteral Nutrition, Total; Short Bowel Syndrome; Ursodeoxycholic Acid | 1994 |
A 20-year-old woman with portal hypertension and a cholestatic syndrome.
Topics: Adult; Biopsy; Cholestasis; Diagnosis, Differential; Female; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Prognosis; Ursodeoxycholic Acid | 1994 |
Variable effect of ursodeoxycholic acid on cyclosporin absorption after orthotopic liver transplantation.
Topics: Absorption; Adolescent; Adult; Aged; Biological Availability; Cholestasis; Cyclosporine; Female; Graft Rejection; Half-Life; Humans; Liver; Liver Transplantation; Male; Middle Aged; Transplantation, Homologous; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bile; Bile Acids and Salts; Cholestasis; Ethinyl Estradiol; Female; Rats; Rats, Sprague-Dawley; Sucrose; Ursodeoxycholic Acid | 1993 |
Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
Topics: Animals; Bile Acids and Salts; Cholagogues and Choleretics; Cholestasis; Cyclosporine; Male; Rats; Rats, Sprague-Dawley; Solutions; Taurine; Ursodeoxycholic Acid; Viscosity | 1993 |
Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
Topics: Alkaline Phosphatase; Animals; Bile; Bile Acids and Salts; Cholestasis; L-Lactate Dehydrogenase; Liver; Male; Rats; Rats, Wistar; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1993 |
Protection against alpha-naphthylisothiocyanate-induced acute cholestasis in mice by a novel taurine conjugate of ursodeoxycholate (UR-906).
Topics: 1-Naphthylisothiocyanate; Administration, Oral; Animals; Bile Acids and Salts; Bilirubin; Biomarkers; Cholestasis; L-Lactate Dehydrogenase; Liver; Male; Mice; Taurine; Ursodeoxycholic Acid | 1993 |
Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Topics: Animals; Bile Ducts; Cell Division; Cholestasis; Common Bile Duct; Drug Evaluation, Preclinical; Ligation; Liver; Male; Rats; Rats, Sprague-Dawley; Time Factors; Ursodeoxycholic Acid | 1993 |
Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.
Topics: Animals; Bile; Cholestasis; Glucuronates; Hyperbilirubinemia, Hereditary; Lithocholic Acid; Liver; Male; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1993 |
[Experimental study on the effects of endotoxemia as a retardation-factor influencing on the decrease of serum bilirubin after the relief of obstructive jaundice].
Topics: Animals; Bilirubin; Cholestasis; Endotoxins; Male; Methylprednisolone; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid | 1993 |
Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Topics: Animals; Bile; Cholagogues and Choleretics; Cholestasis; Estradiol; Hyperbilirubinemia, Hereditary; Isomerism; Male; Rats; Rats, Mutant Strains; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1993 |
[Results of 4 years of gallstone lithotripsy].
Topics: Adult; Aged; Aged, 80 and over; Chenodeoxycholic Acid; Cholecystectomy; Cholelithiasis; Cholestasis; Colic; Female; Humans; Lithotripsy; Male; Middle Aged; Pancreatitis; Recurrence; Retrospective Studies; Ursodeoxycholic Acid | 1993 |
Hepatic lymph nodes as follow-up factor in primary biliary cirrhosis. An ultrasound study.
Topics: Adult; Aged; Cholestasis; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Lymph Nodes; Male; Middle Aged; Ultrasonography; Ursodeoxycholic Acid | 1995 |
Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Topics: Adolescent; Adult; Bile; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Female; Humans; Lipid Metabolism; Male; Middle Aged; Ursodeoxycholic Acid | 1995 |
Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Topics: Animals; Cholelithiasis; Cholestasis; Isomerism; Male; Rats; Rats, Sprague-Dawley; Taurine; Taurolithocholic Acid; Ursodeoxycholic Acid | 1996 |
Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
Topics: Anticholesteremic Agents; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1996 |
Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Cholic Acids; Female; Humans; Infant, Newborn; Oxidoreductases; Ursodeoxycholic Acid | 1996 |
Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholestasis; Cholic Acid; Cholic Acids; Chromatography, High Pressure Liquid; Cyclosporine; Fasting; Female; Glycocholic Acid; Heart Transplantation; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Lithocholic Acid; Male; Middle Aged; Spectrophotometry, Ultraviolet; Taurocholic Acid; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
Topics: Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cholestasis; gamma-Glutamyltransferase; Gastrointestinal Agents; Humans; Infant; Male; Parenteral Nutrition, Total; Pilot Projects; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1996 |
Hepatitis and cholestasis in a middle-aged woman.
Topics: Adult; Azathioprine; Cholestasis; Drug Therapy, Combination; Female; Hepatitis; Humans; Prednisone; Ursodeoxycholic Acid | 1996 |
Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets.
Topics: Animals; Animals, Newborn; Bile; Cholestasis; Injections, Intravenous; Lipids; Parenteral Nutrition, Total; Sodium-Potassium-Exchanging ATPase; Swine; Ursodeoxycholic Acid | 1996 |
Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoimmunity; Bilirubin; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Giant Cells; Hepatitis; Histocytochemistry; HLA Antigens; Humans; Immunosuppressive Agents; Male; Serology; Ursodeoxycholic Acid | 1996 |
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei.
Topics: Adult; Animals; Bile Acids and Salts; Cell Nucleus; Cholestasis; Humans; Liver; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1997 |
Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice.
Topics: Analysis of Variance; Animals; Bile Acids and Salts; Cholestasis; Endotoxemia; Injections, Intravenous; Lipopolysaccharides; Male; Rats; Rats, Wistar; Ursodeoxycholic Acid | 1997 |
Urinary 1 beta-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy.
Topics: Cholagogues and Choleretics; Cholestasis; Deoxycholic Acid; Gas Chromatography-Mass Spectrometry; Humans; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid in the management of prolonged cholestasis of acute hepatitis B.
Topics: Acute Disease; Adult; Cholagogues and Choleretics; Cholestasis; Hepatitis B; Humans; Male; Ursodeoxycholic Acid | 1997 |
Nonsyndromic paucity of interlobular bile ducts: clinical and laboratory findings of 10 cases.
Topics: Bile Ducts; Biopsy; Child, Preschool; Cholestasis; Cholestyramine Resin; Consanguinity; Female; Humans; Infant; Jaundice; Liver; Liver Function Tests; Liver Transplantation; Male; Phenobarbital; Prednisolone; Prognosis; Pruritus; Ursodeoxycholic Acid; Vitamins | 1997 |
Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes.
Topics: Angiotensin II; Animals; Bile; Bile Acids and Salts; Cells, Cultured; Cholestasis; Colforsin; Common Bile Duct; Cricetinae; Cyclic AMP; Glucagon; Isoenzymes; Kinetics; Liver; Male; Mesocricetus; Protein Kinase C; Protein Kinase C-alpha; Receptors, Glucagon; Reference Values; Taurocholic Acid; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis.
Topics: Cholagogues and Choleretics; Cholestasis; Cystic Fibrosis; Female; Humans; Infant, Newborn; Liver Function Tests; Male; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats.
Topics: Animals; Bile; Bile Acids and Salts; Cholestasis; Estradiol; Female; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1997 |
Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection.
Topics: Acute Disease; Cholestasis; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 1998 |
Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL.
Topics: Angiotensin II; Animals; Cholestasis; Colforsin; Common Bile Duct; Cricetinae; Cyclic AMP; Glucagon; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; GTP-Binding Proteins; Keratins; Ligation; Liver; Male; Mesocricetus; Receptors, Glucagon; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1998 |
Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases.
Topics: Animals; ATP-Dependent Proteases; Calcium Channels; Calpain; Cholestasis; Enzyme Activation; Glycochenodeoxycholic Acid; Liver; Mitochondria, Liver; Necrosis; Permeability; Serine Endopeptidases; Ursodeoxycholic Acid | 1998 |
Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
Topics: Acute Disease; Adult; Bile Duct Diseases; Biopsy; Child; Cholestasis; Female; Humans; Ibuprofen; Liver; Liver Cirrhosis; Prednisone; Stevens-Johnson Syndrome; Tacrolimus; Time Factors; Ursodeoxycholic Acid | 1998 |
[Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestasis; Clavulanic Acid; Humans; Male; Penicillins; Ursodeoxycholic Acid | 1998 |
Cholestasis of pregnancy: ursodeoxycholic acid therapy.
Topics: Cholagogues and Choleretics; Cholestasis; Female; Humans; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1998 |
[Cholestasis: drug therapy].
Topics: Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Ursodeoxycholic Acid | 1998 |
[Inhibition of the antioxidant protection, microsomal oxidation, and xenobiotic glucuroconjugation in rats with cholestasis and their regulation].
Topics: Animals; Antioxidants; Cholestasis; Glucuronates; Liver; Male; Microsomes, Liver; Mixed Function Oxygenases; Nikethamide; Oxidation-Reduction; Phosphatidylcholines; Rats; S-Adenosylmethionine; Ursodeoxycholic Acid; Xenobiotics | 1999 |
Influence of cholestasis on absorption of ursodeoxycholic acid.
Topics: Administration, Oral; Aged; Bile Acids and Salts; Bilirubin; Cholagogues and Choleretics; Cholestasis; Drainage; Female; Humans; Intestinal Absorption; Male; Middle Aged; Pancreatic Neoplasms; Ursodeoxycholic Acid | 1999 |
Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury.
Topics: Animals; Cholagogues and Choleretics; Cholestasis; Cytochrome P-450 Enzyme System; Deoxycholic Acid; Liver; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ursodeoxycholic Acid | 1999 |
[Management of cholestasis in pregnancy].
Topics: Cholestasis; Female; Humans; Pregnancy; Pregnancy Complications; Pruritus; Ursodeoxycholic Acid | 1999 |
[Disturbed functioning of enzyme systems of the microsomal oxidation, glucuro- and glutathione conjugation of xenobiotics in the liver of rats intoxicated by deoxycholate and their correction].
Topics: Animals; Cholagogues and Choleretics; Cholestasis; Deoxycholic Acid; Glucuronates; Glutathione; Male; Microsomes, Liver; Nikethamide; Rats; S-Adenosylmethionine; Ursodeoxycholic Acid; Vitamin E; Xenobiotics | 2000 |
Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Topics: Animals; Bile; Bile Acids and Salts; Bile Ducts; Body Weight; Cholestasis; Cholic Acids; Eating; Ligation; Liver; Liver Function Tests; Male; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 2001 |
Arthrogryposis, renal dysfunction and cholestasis syndrome.
Topics: Abnormalities, Multiple; Acidosis, Renal Tubular; Arthrogryposis; Atrophy; Cholestasis; Consanguinity; Corpus Callosum; Female; Genes, Recessive; Hearing Loss, Sensorineural; Heart Defects, Congenital; Humans; Infant, Newborn; Pedigree; Retrospective Studies; Saudi Arabia; Syndrome; Ursodeoxycholic Acid | 2000 |
Flipping over flippases.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Female; Gene Deletion; Genes, MDR; Humans; Infant; Infant, Newborn; Male; Mice; Mice, Knockout; Middle Aged; Mutation, Missense; Ursodeoxycholic Acid | 2001 |
Mucolipidosis II (I-cell disease) presenting as neonatal cholestasis.
Topics: Bile Ducts; Cholestasis; Female; Humans; Infant, Newborn; Liver; Liver Function Tests; Mucolipidoses; Ultrasonography; Ursodeoxycholic Acid | 2001 |
Acute cholestatic hepatitis after exposure to isoflurane.
Topics: Acetylcysteine; Acute Disease; Aged; Anesthetics, Inhalation; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Humans; Isoflurane; Liver; Liver Function Tests; Ursodeoxycholic Acid | 2002 |
The UDCA dosage deficit: a fate shared with CDCA.
Topics: Chenodeoxycholic Acid; Cholelithiasis; Cholestasis; Dose-Response Relationship, Drug; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2002 |
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Topics: Animals; Apoptosis; Bile Acids and Salts; Bile Ducts; Calcium; Carrier Proteins; Cell Division; Cholagogues and Choleretics; Cholestasis; Down-Regulation; Hepatitis; Hydroxysteroid Dehydrogenases; Isoenzymes; Ligation; Liver; Male; Membrane Glycoproteins; Organ Size; Protein Kinase C; Protein Kinase C-alpha; Rats; Rats, Inbred F344; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2002 |
[Ursodeoxycholic acid promotes liver regeneration after partial hepatectomy in bile duct obstructive rats].
Topics: Animals; Cholestasis; Gene Expression Regulation; Hepatectomy; Hepatocyte Growth Factor; Liver; Liver Regeneration; Male; Proto-Oncogene Proteins c-met; Rats; Rats, Wistar; RNA, Messenger; Ursodeoxycholic Acid | 2002 |
Treatment of severe cholestasis in neonatal Dubin-Johnson syndrome with ursodeoxycholic acid.
Topics: Bilirubin; Cholestasis; Humans; Hyperbilirubinemia; Infant, Newborn; Jaundice, Chronic Idiopathic; Male; Ursodeoxycholic Acid | 2002 |
[Ursotherapy in hepatobiliary diseases].
Topics: Chenodeoxycholic Acid; Cholelithiasis; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis.
Topics: 5'-Nucleotidase; Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Child; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Ursodeoxycholic Acid | 1992 |
Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver.
Topics: Animals; Aspartate Aminotransferases; Bile; Cholestasis; Colchicine; gamma-Glutamyltransferase; Male; Microtubules; Rats; Rats, Inbred Strains; Secretory Rate; Taurochenodeoxycholic Acid; Taurocholic Acid; Ursodeoxycholic Acid | 1992 |
[Drug therapy of cholestatic hepatopathies].
Topics: Cholangitis, Sclerosing; Cholestasis; Humans; Liver Cirrhosis, Biliary; Long-Term Care; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Topics: Animals; Cholestasis; Hemodynamics; Hypertension, Portal; Liver; Male; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid | 1992 |
Lack of benefit of ursodeoxycholic acid in drug-induced cholestasis in the rat.
Topics: 1-Naphthylisothiocyanate; Animals; Cholestasis; Cyclosporine; Ethinyl Estradiol; Male; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid | 1992 |
The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids.
Topics: Adult; Aged; Bile Acids and Salts; Cholangitis, Sclerosing; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 1992 |
Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
Topics: Acetylglucosamine; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Deoxycholic Acid; Glycosides; Humans; Hydroxylation; Liver Diseases; Mass Spectrometry; Ursodeoxycholic Acid | 1992 |
Synthesis of 13C-labeled chenodeoxycholic, hyodeoxycholic, and ursodeoxycholic acids for the study of bile acid metabolism in liver disease.
Topics: Administration, Oral; Carbon Isotopes; Chenodeoxycholic Acid; Cholestasis; Chromatography, Thin Layer; Deoxycholic Acid; Gas Chromatography-Mass Spectrometry; Humans; Isotope Labeling; Spectrophotometry, Infrared; Ursodeoxycholic Acid | 1991 |
Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis.
Topics: Amino Acids; Animals; Bicarbonates; Bile; Bile Acids and Salts; Canrenoic Acid; Cholagogues and Choleretics; Cholestasis; Glucose; Infusions, Intravenous; Swine; Ursodeoxycholic Acid | 1991 |
Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report.
Topics: Adult; Cholestasis; Humans; Male; Parenteral Nutrition, Home; Time Factors; Ursodeoxycholic Acid | 1991 |
Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
Topics: Adult; Aminopyrine; Bile; Bile Acids and Salts; Carbon Isotopes; Carbon Radioisotopes; Cholestasis; Female; Humans; Intestines; Liver Diseases; Male; Microsomes, Liver; Middle Aged; Ursodeoxycholic Acid | 1991 |
[Use of ursodeoxycholic acid in the treatment of hepato-biliary complications in cystic fibrosis].
Topics: Adolescent; Adult; Child; Cholestasis; Cystic Fibrosis; Female; Humans; Liver; Male; Ursodeoxycholic Acid | 1991 |
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
Topics: Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid | 1991 |
Cystic fibrosis: another use for urso?
Topics: Adolescent; Adult; Child; Cholestasis; Cystic Fibrosis; Humans; Liver; Nutritional Status; Ursodeoxycholic Acid | 1991 |
Liver dysfunction in cystic fibrosis--beneficial effect of bile acid treatment.
Topics: Bile Acids and Salts; Child; Cholestasis; Cystic Fibrosis; Humans; Liver Function Tests; Taurine; Ursodeoxycholic Acid | 1991 |
Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid.
Topics: Alkaline Phosphatase; Cholestasis; Cyclosporins; Heart Transplantation; Humans; Ursodeoxycholic Acid | 1991 |
Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid.
Topics: Cholestasis; Chronic Disease; Humans; Lipoproteins; Ursodeoxycholic Acid | 1991 |
Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract Diseases; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Liver Diseases; Microscopy, Electron; Perfusion; Porphyrins; Protoporphyrins; Rats; Rats, Inbred Strains; Taurocholic Acid; Ursodeoxycholic Acid | 1990 |
Cholesterol and bile acid metabolism in cultures of primary rat bile ductular epithelial cells.
Topics: Animals; Bile Acids and Salts; Bile Ducts; Cell Separation; Cells, Cultured; Cholestasis; Cholesterol; Cholic Acid; Cholic Acids; Deoxycholic Acid; Epithelial Cells; Epithelium; Lithocholic Acid; Male; Rats; Rats, Inbred Strains; Ursodeoxycholic Acid | 1990 |
Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.
Topics: Adolescent; Adult; Child; Cholestasis; Chronic Disease; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Liver; Liver Function Tests; Male; Nutritional Status; Prospective Studies; Ursodeoxycholic Acid | 1990 |
Treatment of primary biliary cirrhosis and cholestatic disorders with ursodeoxycholic acid.
Topics: Cholestasis; Deoxycholic Acid; Double-Blind Method; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Ursodeoxycholic Acid | 1987 |
Prevention of endotoxaemia in obstructive jaundice--a comparative study of bile salts.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Cholic Acid; Cholic Acids; Deoxycholic Acid; Endotoxins; Escherichia coli; Glycodeoxycholic Acid; Intestinal Absorption; Male; Rats; Rats, Inbred Strains; Taurocholic Acid; Taurodeoxycholic Acid; Ursodeoxycholic Acid | 1988 |
Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage.
Topics: Aged; Bile; Bile Acids and Salts; Cefotaxime; Cefotiam; Cholestasis; Deoxycholic Acid; Drainage; Female; Humans; Male; Middle Aged; Penicillin G; Sulbenicillin; Ursodeoxycholic Acid | 1988 |
Endotoxemia in obstructive jaundice. Observations on cause and clinical significance.
Topics: Cholestasis; Endotoxins; Female; Humans; Kidney; Male; Middle Aged; Postoperative Complications; Preoperative Care; Risk Factors; Ursodeoxycholic Acid | 1988 |
[Bile acids in chronic hepatopathies].
Topics: Adult; Bile Acids and Salts; Cholestasis; Chronic Disease; Diagnosis, Differential; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Middle Aged; Ursodeoxycholic Acid | 1986 |
[Effect of ursodeoxycholic acid on biliary excretion of cefotiam in patients with percutaneous transhepatic biliary drainage].
Topics: Aged; Bile; Cefotaxime; Cefotiam; Cholestasis; Deoxycholic Acid; Drainage; Female; Humans; Male; Middle Aged; Ursodeoxycholic Acid | 1985 |